artemether has been researched along with Malaria, Falciparum in 359 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 69 (19.22) | 18.2507 |
| 2000's | 102 (28.41) | 29.6817 |
| 2010's | 95 (26.46) | 24.3611 |
| 2020's | 93 (25.91) | 2.80 |
| Authors | Studies |
|---|---|
| Brun, R; Charman, SA; Charman, WN; Chiu, FC; Chollet, J; Dong, Y; Dorn, A; Karle, JM; Matile, H; Santo Tomas, J; Scheurer, C; Scorneaux, B; Snyder, C; Tang, Y; Urwyler, H; Vennerstrom, JL; Wang, X; Wittlin, S | 1 |
| Agarwal, P; Dodda, RP; Krishna, NN; Kumar, A; Puri, SK; Sashidhara, KV; Srivastava, K | 1 |
| Fidock, DA; Flannery, EL; Winzeler, EA | 1 |
| Ako, BA; Assi, SB; Coulibaly, B; Gbessi, EA; Gnondjui, A; Jambou, R; Koui, TS; Sanogo, I; Sokouri, DP; Tiacoh, NL; Toure, OA | 1 |
| Chapotera, G; Chirwa, T; D'Alessandro, U; Kazembe, L; Laufer, MK; Mathanga, D; Mukaka, M; Mwapasa, V; Patson, N | 1 |
| Assefa, DG; Makonnen, E; Yismaw, G | 1 |
| Abla, N; Barber, BE; Barnes, KI; Boyle, MJ; Chalon, S; Chughlay, MF; El Gaaloul, M; Engwerda, CR; Griffin, P; Kress, A; Marquart, L; McCarthy, JS; Möhrle, JJ; Reuter, SE; Schultz, HB; Tapley, P; van Giersbergen, P; Webster, RA; Wells, T | 1 |
| Gustafsson, L; James, S; Thozhuthumparambil, KP; Zhang, Y | 1 |
| Abuaku, B; Afriyie, PO; Bart-Plange, C; Duah-Quashie, NO; Ghansah, A; Gyasi, A; Koram, KA; Malm, KL; Owusu-Antwi, F; Quashie, N | 1 |
| Aboh, PM; Adzemye, LM; Akam, LF; Ali, IM; Alifrangis, M; Ambani, MCE; Ango, Z; Bigoga, JD; Chedjou, JPK; Dinza, G; Dongmo, CH; Douanla, A; Ewane, MS; Fomboh, CT; Fosah, DA; Kotcholi, GB; Ludovic, AJ; Mbacham, WF; Moyeh, MN; Nana, WD; Ndikum, VN; Ngu, JA; Niba, PTN; Nji, AM; Nna, DRA; Oben, OLA; Omgba, PAM; Selly-Ngaloumo, AA; Tatah, FM; Ticha, JT | 1 |
| Baraka, V; Kamugisha, E; Kapesa, A; Kidenya, B; Konje, E; Marwa, K; Mukonzo, J; Swedberg, G | 1 |
| Amaratunga, C; Callery, JJ; Chau, NH; Chotivanich, K; Chotsiri, P; Day, NPJ; Dhorda, M; Dondorp, AM; Duanguppama, J; Dung, NTP; Hien, TT; Hoglund, RM; Imwong, M; Lek, D; Long, LT; Maude, RJ; Miotto, O; Mukaka, M; Nghia, HDT; Nguon, C; Peto, TJ; Rekol, H; Ruecker, A; Sokha, M; Sovann, Y; Tarning, J; Thuong, NTH; Tripura, R; van der Pluijm, RW; Van Luong, V; von Seidlein, L; Waithira, N; White, NJ | 1 |
| Bauleni, A; Buchwald, AG; Chilombe, M; Coalson, JE; Cohee, LM; Laufer, MK; Mathanga, DP; Ngwira, A; Peterson, I; Schaffer-DeRoo, S; Seydel, KB; Taylor, TE; Valim, C; Wilson, ML | 1 |
| Bottieau, E; Huits, R; Rosanas-Urgell, A; Tournoy, TK; Van Esbroeck, M | 1 |
| Atieli, H; Debrah, I; Githeko, AK; Githure, J; Kazura, J; Lee, MC; Magomere, EO; Mukabana, WR; Ochwedo, KO; Olumeh, JO; Onyango, P; Otambo, WO; Ouma, C; Wang, C; Yan, G; Zhou, G | 1 |
| Asinya, M; Jeuronlon, MK; Kamara, P; Koko, VS; Kollie, A; Ma, L; Menard, D; Nyansaiye, P; Parwon, S; Pratt, OJ; Ringwald, P; Taweh, F; Tehmeh, L; Vonhm, B; Warsame, M | 1 |
| Ashaba, FK; Edgar, K; Kamya, MR; Mwesigwa, S; Nsobya, SL; Ocan, M | 1 |
| Grundmann, O; Hernandez Maldonado, J | 1 |
| Balizou, O; Biago, U; Gody, JC; Moyen, M; Nambei, WS; Ndoua, C; Pounguinza, S | 1 |
| Batty, KT; Bwire, GM; Davis, TME; Makani, J; Manning, L; Minzi, OMS; Moore, BR; Ngasala, B; Page-Sharp, M; Salman, S; Sugiarto, SR | 1 |
| Adeniji, OE; Amambua-Ngwa, A; Amawu, AU; Correa, S; Faal, F; Heinz, E; Hughes, G; Meremikwu, MM; Oboh, MA; Ogban, E | 1 |
| Obonyo, CO; Ogutu, BR | 1 |
| Amante, FH; Barber, BE; Birrell, GW; Edstein, MD; Gower, J; Heunis, J; Jennings, H; Llewellyn, S; Lynch, S; Marquart, L; McCarthy, JS; Mitchell, H; O'Neill, B; Peters, JM; Potter, AJ; Shanks, GD; Webster, R | 1 |
| Baguiya, A; Barry, N; Hien, D; Kaboré, JMT; Siribié, M; Sirima, SB; Soulama, I; Tchouatieu, AM; Tiono, AB | 1 |
| Abuom, D; Akala, HM; Andagalu, B; Chemwor, G; Cheruiyot, A; Cowden, J; Juma, D; Kamau, E; Ogutu, B; Okoth, R; Okudo, C; Onyango, I; Opot, B; Sifuna, P; Wafubwa, J; Watson, OJ; Yalwala, S; Yeda, R | 1 |
| Amoh, G; Amuzu, DSY; Andoh, NE; Ansong, M; Hirst, J; Nyaaba, N; Ordóñez-Mena, JM | 1 |
| Amambua-Ngwa, A; Bojang, F; D'Alessandro, U; Demba, MA; Diop, MF; Jeffries, D; Mane, K; Mbye, H; Mohammed, NI; Quashie, NB | 1 |
| Aguas, R; Boni, MF; Gao, B; Nguyen, TD; Okell, L; Penny, MA; Smith, DL; Tran, TN; Watson, OJ | 1 |
| Abdallah, KS; Bacar, A; Deng, C; Li, G; Li, M; Liu, R; Lu, C; Silai, R; Song, J; Tan, R; Wu, W; Xu, Q; Yuan, Y; Zhang, H; Zheng, S | 1 |
| Amambua-Ngwa, A; Dugassa, S; Golassa, L; Jaiteh, FK; Oboh, M; Oriero, E; Tadele, G | 1 |
| Buff, AM; Chebore, W; Desai, M; Kariuki, S; Otieno, K; Owidhi, M; Samuels, AM; Westercamp, N | 1 |
| Kamugisha, E; Konje, ET; Liwa, AC; Marwa, KJ; Mwita, S; Swedberg, G | 1 |
| Aweeka, FT; Colt, M; Goodwin, J; Huang, L; Kajubi, R; Li, F; Mwebaza, N; Orukan, F; Parikh, S; Richards, K; Wang, K; Whalen, ME | 1 |
| Callery, JJ; Chotthanawathit, P; Conradis-Jansen, F; Dondorp, AM; Duanguppama, J; Ean, M; Heng, C; Imwong, M; Jongdeepaisal, M; Khonputsa, P; Madmanee, W; Maude, RJ; Mukaka, M; Peerawaranun, P; Pell, C; Peto, TJ; Pongsoipetch, K; Rekol, H; Sokha, M; Sovannaroth, S; Soviet, U; Tarning, J; Tripura, R; von Seidlein, L; Waithira, N; White, NJ | 1 |
| Dondorp, AM; Maude, RJ; Tarning, J; von Seidlein, L; White, NJ | 1 |
| Alemayehu, GS; Dinka, H; Golassa, L; Hassen, J | 1 |
| Aweeka, F; Ehrlich, H; Freeman, T; French, J; Goodwin, J; Huang, L; Kajubi, R; Kay, K; Li, F; Mwebaza, N; Ou, J; Parikh, S; Riggs, M; Ruiz-Garcia, A; Wade, M; Wang, K | 1 |
| Bibe, AF; Earland, DE; Ferrão, J; Novela, A; Searle, KM | 1 |
| Chenet, SM; Cortés, LJ; Guerra, AP; Lucchi, NW; Macedo de Oliveira, A; Olivera, MJ | 1 |
| Abuaku, B; Afrane, Y; Amoah, LE; Cui, L; Duah-Quashie, NO; Duan, M; Huang, Y; Li, X; Pan, M; Qin, Y; Sun, K; Wang, X; Yang, Q; Yang, Z; Zeng, W; Zhao, H; Zhao, W; Zhou, L; Zhu, W | 1 |
| Adegnika, AA; Akinosho, MA; Davi, SD; Dimessa-Mbadinga, LB; Handrich, C; Kreidenweiss, A; Kremsner, PG; Lell, B; Mombo-Ngoma, G; Ndzebe-Ndoumba, WF; Nordmann, T; Okwu, DG; Ramharter, M; Stelzl, D; Veletzky, L; Zoleko-Manego, R | 1 |
| Andrianaranjaka, VHI; Dodoson, BT; Fenomanana, J; Rakotoarisoa, MA; Ratsimbasoa, A | 1 |
| Augusto, O; Byamugisha, J; Clerk, C; Dellicour, S; Desai, M; Gomes, M; Guérin, PJ; Hill, J; Kagawa, M; Kariuki, S; Kisinza, W; Manyando, C; McGready, R; Mehta, U; Mosha, D; Mrema, S; Njunju, EM; Nosten, F; Rouamba, T; Rulisa, S; Saito, M; Sevene, E; Singlovic, J; Stepniewska, K; Stergachis, A; Ter Kuile, FO; Tinto, H; Vala, A; van Eijk, AM; Were, E; Yore, M | 1 |
| Abera, A; Alemayehu, BH; Anand, A; Assefa, A; Bekele, W; Dilu, D; Etana, K; Ezema, B; Girma, S; Haile, M; Hwang, J; Minta, AA; Mohammed, H; Moriarty, LF; Murphy, M; Sime, H; Solomon, H; Svigel, SS; Tadesse, M; Tadesse, Y; Tasew, G; Teka, H; Woyessa, A; Zhou, Z | 1 |
| Abongo, G; Basara, BB; Baseke, J; Bongo, GS; Day, NJP; Dhorda, M; Dondorp, AM; Fanello, C; Kayembe, DK; Maitland, K; Muhindo, R; Mukaka, M; Namayanja, C; Ndjowo, PO; Okalebo, CB; Olupot-Olupot, P; Onyamboko, MA; Onyas, P; Peerawaranun, P; Tarning, J; Taya, C; Taylor, WR; Titin, H; Uyoga, S; Waithira, N; Weere, W; Williams, TN | 1 |
| Falade, CO; Funwei, RI; Hammed, WA; Ojurongbe, O; Uyaiabasi, GN; Walker, O | 1 |
| Abay, SM; Assefa, A; Assefa, G; Bekele, W; Gidey, B; Gubae, K; Haile, M; Hailgiorgis, H; Mare, AK; Mohammed, H; Sime, H; Tasew, G | 1 |
| Ackerman, HC; Carvalho, LJ; Daniel-Ribeiro, CT; Gul, S | 1 |
| Adams, M; Buchwald, AG; Divala, TH; Earland, DE; Laufer, MK; Laurens, MB; Mallewa, JE; Miller, J; Mungwira, RG; Nampota-Nkomba, N; Nyangulu, W; Nyirenda, OM; Parikh, S; Plowe, CV; Taylor, TE; van Oosterhout, JJ | 1 |
| Mace, KE; Schultz, JS; Tan, KR | 1 |
| Abd-Rahman, AN; Barber, BE; Birrell, GW; Edstein, MD; Leelasena, I; Llewellyn, S; Marquart, L; McCarthy, JS; Moehrle, JJ; Potter, AJ; Sahai, N; Shanks, GD; Webster, R; Wesche, D | 1 |
| Adjei, GO; Ahorhorlu, SY; Alifrangis, M; Duah-Quashie, NO; Dzudzor, B; Hansson, H; Jensen, RW; Kudzi, W; Nartey, ET; Quashie, NB; Wang, CW; Zoiku, F | 1 |
| Adebayo, IA; Adeyemo, RO; Akinola, SA; Albert, O; Bwogo, P; John, O; Maniga, JN; Martin, O; Muchiri, JN; Onkoba, SK; Rael, M; Samuel, M; Sankarapandian, V; Wilberforce, M | 1 |
| Batty, KT; Davis, TME; Kasian, B; Laman, M; Lorry, L; Manning, L; Moore, BR; Pomat, W; Robinson, LJ; Salman, S; Tesine, P; Woon, SA; Yadi, G; Yambo, P | 1 |
| Bogoch, II; Halani, S | 1 |
| Ahmed, RA; Begum, A; Hussain, SSA; Kalita, D; Kumar, A; Kumar, G; Shankar, H; Singh, K; Suri, HS; Swargiary, A | 1 |
| Akala, HM; Amwoma, JG; Andagalu, BM; Chemwor, GC; Cheruiyot, AC; Egbo, TE; Garges, EC; Juma, DW; Juma, JA; Kamau, E; Mwakio, EW; Ogutu, BR; Okoth, RO; Onyango, IA; Opot, BH; Roth, AL; Wakoli, DM; Watson, OJ; Yedah, RA | 1 |
| Aygen, B; Kalın Ünüvar, G; Türe, Z; Yaman, O; Yıldız, O | 1 |
| Djissem, PE; Manyeh, AK; Tetteh, JA | 1 |
| Aina, O; Awolola, ST; Babatunde, S; David, AN; Ekama, SO; Happi, CT; Ijezie, SN; Mohammed, AB; Mokuolu, O; Musa, AZ; Ogbulafor, N; Oguche, S; Okafor, H; Olukosi, AY; Ozor, L; Salako, BL; Uhomoibhi, PE; Wammanda, R | 1 |
| Adehossi, E; Arzika, II; Lamine, MM; Lobo, NF; Mahamadou, A; Mahmud, O; Maman Laminou, I; Sandrine, H; Sarr, D; Sarrasin-Hubert, V; Tidjani, IA | 1 |
| Adedapo, AD; Anjorin, OE; Falade, CO; Funwei, RI; Michael, OS; Mokuolu, OA; Olusanya, AL; Olusola, FI; Orimadegun, AE; Orimadegun, BE | 1 |
| Chepngetich, J; Gachie, B; Gathirwa, J; Kiboi, D; Kimani, F; Magoma, G; Muriithi, B; Mwitari, P; Onchieku, N; Thiong'o, K | 1 |
| Buzibye, A; Nakalembe, L; Nsobya, S; Ocan, M; Omali, D; Otike, C | 1 |
| Amambua-Ngwa, A; Dugassa, S; Golassa, L; Jawara, A; Oboh, M; Oriero, E; Tadele, G | 1 |
| Chikoto, H; Csermak, K; Demin, I; El Gaaloul, M; Fofana, B; Grobusch, MP; Kaguthi, G; Kibuuka, A; Kusemererwa, S; Lingani, M; Lourenço, C; Marrast, AC; Mehta, D; Mombo-Ngoma, G; N'Guessan, TL; Nassa, GJW; Nduba, V; Nyantaro, M; Ogutu, B; Pathan, R; Risterucci, C; Singh, PK; Su, G; Thompson, R; Tina, LO; Tinto, H; Toure, AO; Uthaisin, C; Verma, A; Winnips, C; Yeka, A | 1 |
| Bernieri, F; Cavallari, S; Doderer-Lang, C; Guidetti, C; L'Episcopia, M; Menard, D; Perrotti, E; Priuli, GB; Severini, C | 1 |
| Aide, P; Baraka, V; Bassat, Q; Cousin, M; David, A; Gesase, S; Gwasupika, J; Hachizovu, S; Makenga, G; Manyando, C; Nhama, A; Ntizimira, CR; Obunge, O; Otsyula, N; Pathan, R; Risterucci, C; Su, G; Tshefu, KA | 1 |
| Abdelkader, O; Boulotigam, K; Djimadoum, M; Djimrassengar, H; Doderer-Lang, C; Hassoumi, M; Issa, AH; Issa, MS; Mahamat, MHT; Menard, D; Ndihiokubwayo, JB; Rasmussen, C; Saleh, IDM; Warsame, M | 1 |
| Boni, MF; Kabera, M; Li, H; Ngabonziza, JCS; Nguyen, TD; Tran, KT; Tran, TN; Uwimana, A; Zupko, RJ | 1 |
| Cai, J; Chen, G; Hu, G; Jin, L; Li, J; Li, Q; Li, S; Li, Y; Qian, J; Zhang, X; Zhou, Q | 1 |
| D'Alessandro, U; Dabira, ED; Diakite, H; Djimde, M; Dorlo, TP; Erhart, A; González, R; Kabore, B; Kayentao, K; Keita, M; Macuacua, S; Menendez, C; Mens, P; Muhindo, HM; Piqueras, M; Sagara, I; Schallig, H; Sevene, E; Tinto, H; Traore, M; Tshiongo, JK; Vala, A | 1 |
| Bamisaiye, A; Basara, BB; Baseke, J; Day, NPJ; Fanello, C; Kayembe, DK; Maitland, K; Muhindo, R; Mukaka, M; Namayanja, C; Ndjowo, PO; Okalebo, CB; Olupot-Olupot, P; Onyamboko, MA; Onyas, P; Taya, C; Taylor, WRJ; Titin, H; Uyoga, S; Were, W; Williams, TN | 1 |
| Acharya, S; Arnold, L; Chico, RM; Gore-Langton, GR; Lufele, E; Moore, BR; Price, RN; Rogerson, SJ; Ter Kuile, FO; Thriemer, K; Unger, HW; van Eijk, AM; Wu, C | 1 |
| Ahoua Alou, LP; Camara, S; Koffi, AA; N'Guessan, B; N'Guessan, R; Oumbouke, WA; Rowland, M; Thomas, MB; Tia, IZ; Wolie, RZ; Zoh, MG | 1 |
| Abate, DT; Alam, MS; Anose, RT; Baird, JK; Christian, M; Degaga, TS; Ekawati, LL; Hailu, A; Hossain, MS; Karahalios, A; Kibria, MG; Kiros, FG; Lee, G; Ley, B; Mnjala, H; Panggalo, LV; Price, RN; Rajasekhar, M; Rumaseb, A; Sadhewa, A; Satyagraha, AW; Simpson, JA; Sutanto, I; Tego, TT; Thriemer, K; Weston, S; Woyessa, A | 1 |
| Obiebi, IP | 1 |
| Fungula, B; Inocencio da Luz, R; Kalabuanga, M; Lula Ntamba, Y; Lutumba, P; Muhindo Mavoko, H; Ntamabyaliro Nsengi, PM; Tona Lutete, G; Van Geertruyden, JP | 1 |
| Badjanga, BB; Day, NPJ; Fanello, C; Hoglund, RM; Jackson, NV; Kabedi, C; Kayembe, D; Lee, SJ; McGready, R; Nosten, F; Onyamboko, MA; Tarning, J; Turner, GDH; White, NJ | 1 |
| Aweeka, F; Huang, L; Hughes, E; Kajubi, R; Mwebaza, N; Mwima, MW; Nguyen, V; Nyunt, MM; Orukan, F; Parikh, S | 1 |
| Beshir, KB; Lubis, CP; Lubis, IND; Lubis, M; Sutherland, CJ; Wijaya, H | 1 |
| Arroyo-Arroyo, MI; Barnes, KI; Bastiaens, GJH; Bjorkman, A; Bousema, T; Brown, JM; Chen, I; Craig, E; D'Alessandro, U; Dicko, A; Drakeley, CJ; El-Sayed, BB; Elzaki, SG; Eziefula, AC; Gonçalves, BP; Gosling, R; Guerin, PJ; Humphreys, GS; Kariuki, S; Kwambai, TK; Maestre, AE; Martensson, A; Mosha, D; Mwaiswelo, RO; Ngasala, BE; Okebe, J; Price, RN; Raman, J; Roh, ME; Samuels, AM; Sawa, P; Smit, MR; Stepniewska, K; Stone, WJR; Tiono, AB | 1 |
| Cargill, Z; Chu, C; Gilder, ME; McGready, R; Min, AM; Nosten, F; Phyo, AP; Poe, H; Saito, M; San, TD; White, NJ; Yotyingaphiram, W | 1 |
| Denti, P; Kawuma, AN; Khoo, S; Lamorde, M; Pillai, GC; Walimbwa, SI; Wasmann, RE | 1 |
| Alessandri, F; Angeletti, S; Bazzardi, R; Ceccarelli, G; Celani, L; Ciccozzi, M; D'Ettorre, G; De Angelis, M; Fontanelli Sulekova, L; Gabrielli, S; Lopalco, M; Mattiucci, S; Mazzocato, V; Pugliese, F; Ruberto, F; Spagnolello, O; Vita, S | 1 |
| Baguiya, A; Barry, N; Dianda, F; Héma, A; Hien, D; Kaboré, JMT; Kiba Koumaré, A; Kouanda, S; Nombré, Y; Savadogo, Y; Siribie, M; Sirima, SB; Soulama, I; Tchouatieu, AM; Tiono, AB | 1 |
| Deng, C; Liang, Y; Lu, C; Song, J; Tan, B; Wang, Q; Wu, W; Xu, Q; Zhang, H; Zhou, C | 1 |
| André, K; Bondo, BJ; Cândido, ALM; Caquece, F; Dimbu, PR; Ferreira, CM; Fortes, F; Garcia, LEA; Horth, R; Jandondo, D; Kelley, J; Labuda, S; Lucchi, N; Martins, JF; Morais, JFM; Nieto Andrade, B; Patel, D; Pembele, G; Pluciński, MM; Ponce de León, G; Svigel, SS; Talundzic, E | 1 |
| Abba, T; Angora, EK; Assi, SB; Bedia, VA; Daho, AK; Emmanuel, B; Kiki-Barro, PMC; Konate, AA; Menan, H; Tiacoh, LN; Toure, OA; Yavo, W | 1 |
| Brisibe, A; Charlie-Silva, I; Costa, FTM; Donnelly, RF; Ferreira, LT; Figueiredo, MC; Foglio, MA; Kirkby, M; P Bonfanti, A; Paredes, AJ; Permana, AD; Raposo, C; Sousa, IMO; Volpe-Zanutto, F; Vora, LK | 1 |
| Beshir, KB; Chijioke-Nwauche, I; Nwauche, CA; Oguike, MC; Sutherland, CJ | 1 |
| Bamadio, A; Barry, N; Beshir, KB; Compaore, YD; Coulibaly, M; Coulibaly, SA; Dama, S; Dao, F; Dara, N; Diallo, N; Diarra, A; Djimde, A; Fofana, B; Kaboré, JM; Kabore, NT; Kodio, A; Maurice, OS; Nikiema, F; Ouédraogo, JB; Sagara, I; Sirima, SB; Sombie, S; Somé, FA; Soulama, I; Sutherland, CJ; Togo, AH; Traore, A; Traore, OB; Zongo, I | 1 |
| Bancone, G; Carrara, VI; Chu, C; Duanguppama, J; Gilder, ME; Haohankhunnatham, W; Imwong, M; Konghahong, K; Lee, SJ; McGready, R; Min, AM; Nosten, F; Paw, MK; Phyo, AP; Pimanpanarak, M; Proux, S; Saito, M; Singhasivanon, P; Tun, NW; Turner, C; Viladpai-Nguen, J; White, NJ | 1 |
| Gandhi, P; Renner, KC; Schmitt, EK; Straimer, J | 1 |
| Callery, JJ; Ean, M; Imwong, M; Maude, RJ; Mukaka, M; Peto, TJ; Sokha, M; Sovannaroth, S; Soviet, O; Tarning, J; Tripura, R; von Seidlein, L; Vongpromek, R; Waithira, N | 1 |
| Baptista-Fernandes, T; Benavente, ED; Caldas, JP; Campino, S; Cardoso, M; Clark, TG; Conceição, C; Domingos, J; Mansinho, K; Nogueira, F; Reis, A; Silva-Pinto, A; Toscano, C | 1 |
| Davis, TME; Davis, WA; Hii, KC; Page-Sharp, M; Salman, S; Singh, B; Sugiarto, SR | 1 |
| Asante, KP; Asiimwe, S; Barsainya, S; Boulton, C; Csermak Renner, K; Demin, I; Doumbia, S; Fofana, B; Gandhi, P; Grobusch, MP; Karita, E; Mugerwa, H; Ndayisaba, G; Oduro, A; Sayyed, S; Schmitt, EK; Straimer, J; Su, G; Venishetty, VK; Yeka, A | 1 |
| Genton, B; Hatz, C; Neumayr, A; Paris, DH | 1 |
| Ippolito, MM; Johnson, J; Li, T; Mallow, C; Morgan, N; Mullin, C; Rosenthal, PJ; Wallender, E | 1 |
| Assefa, A; Kassa, M; Mamo, H; Mohammed, H; Teklemariam, M | 1 |
| Ashton, M; Björkman, A; Gil, JP; Mårtensson, A; Ngasala, B; Piedade, R; Sciuto, CL; Vos, K | 1 |
| Nosten, F | 3 |
| van der Pluijm, RW; Watson, J; Woodrow, CJ | 1 |
| Sutherland, CJ | 1 |
| Dwivedi, P; Gao, D; Han, S; Mangrio, FA; Si, T; Xu, RX; Zhao, G | 1 |
| Hasegawa, C; Kimura, M; Kudo, M; Maruyama, H | 1 |
| Akbulut, A; Akbulut, HH; Demirdağ, K; Gökmen Sevindik, Ö; Sağmak Tartar, A | 1 |
| Alifrangis, M; Baraka, V; Francis, F; Lutumba, P; Mavoko, HM; Nabasumba, C; Van Geertruyden, JP | 1 |
| Agarwal, P; Anvikar, AR; Pillai, CR; Srivastava, K | 1 |
| Benito, A; Berzosa, P; Herrador, Z; Ncogo, P; Nseng, G; Riloha, M; Romay-Barja, M; Santana-Morales, MA; Valladares, B | 1 |
| Agaba, S; de Vries, PJ; Dorlo, TPC; Kaligirwa, N; Karlsson, MO; Lohy Das, J; Mens, PF; Rulisa, S; Tarning, J | 1 |
| Aina, OO; Ajibaye, OS; Amambua-Ngwa, A; Awandare, GA; Awolola, TS; Idowu, ET; Olukosi, YA; Otubanjo, OA; Oyebola, KM | 1 |
| Aydin-Schmidt, B; Björkman, A; Di Santi, S; Inoue, J; Islam, A; Jovel, I; Mårtensson, A; Morris, U; Segurado, AC | 1 |
| Akira d'Ávila, M; Brisibe, A; Chorilli, M; Costa Salles, TH; Donnelly, RF; Foglio, MA; Fonseca-Santos, B; Marucci Pereira Tangerina, M; McAlister, E; Oliveira Souza, IM; Vilegas, W; Volpe Zanutto, F | 1 |
| Beavogui, AH; Borghini-Fuhrer, I; Djimdé, AA; Duparc, S; Felices, M; Funck-Brentano, C; Khan, Y; Ouedraogo, JB; Ouologuem, N; Sagara, I; Sirima, SB; Soulama, I; Voiriot, P | 1 |
| Effa, EE; Esu, EB; Meremikwu, MM; Opie, ON | 1 |
| Abdel-Muhsin, AA; Abdelraheem, MH; Al Dhuhli, A; Al Hosni, A; Al Rubkhi, M; Al-Hamidhi, S; Babiker, HA; Bakhiet, AMA; Gadalla, A; Gismelseed, L; Kheir, A; Mukhtar, M; Naiem, A; Omer, S; Sultan, AA | 1 |
| Genton, B; Manong, D; Mueller, I; Rarau, P; Reeder, JC; Rogerson, SJ; Salib, M; Senn, N; Siba, P | 1 |
| Ogutu, B | 1 |
| Rehman, MU; Shrestha, B; Thapa, S; Zehri, T | 1 |
| Dhorda, M; Guerin, PJ; Jullien, V; Kloprogge, F; Nosten, F; Piola, P; Tarning, J; White, NJ | 1 |
| Burkholder, B; Bustos, MD; Delacollette, C; Wongsrichanalai, C | 1 |
| Enweji, N; Gheysari, F; Kaddumukasa, M; Kamugisha, E; Kironde, F; Sendagire, H; Swedberg, G | 1 |
| Li, GX; Wang, W; Wang, YH; Xu, FL; Zhang, XG; Zhao, SS | 1 |
| Bala, N; Betuela, I; Davis, TM; Hetzel, MW; Lavu, EK; Page-Sharp, M; Pulford, J | 1 |
| Amore, A; Calitri, C; Camilla, R; Garazzino, S; Peruzzi, L; Tovo, PA | 1 |
| Albrecht, L; Angerami, RN; Castiñeiras, CM; Costa, FT; Dos-Santos, JC; Garcia, MT; Lacerda, MV; Levy, CE; Lopes, SC; Moretti, ML | 1 |
| Adam, I; Ademowo, G; Arze, C; Baliraine, FN; Berens-Riha, N; Björkman, A; Borrmann, S; Checchi, F; Dahal, P; Davis, TME; Desai, M; Dhorda, M; Djimdé, AA; Dorsey, G; El-Sayed, BB; Eshetu, T; Eyase, F; Falade, C; Faucher, JF; Fröberg, G; Gadalla, NB; Grivoyannis, A; Guérin, P; Hamour, S; Houzé, S; Johnson, J; Kamugisha, E; Kariuki, S; Kiechel, JR; Kironde, F; Kofoed, PE; LeBras, J; Malmberg, M; Mårtensson, A; Ménard, D; Moriera, C; Mwai, L; Ngasala, B; Nosten, F; Nsanzabana, C; Nsobya, SL; Nzila, A; Oguike, M; Ogutu, B; Otienoburu, SD; Ouédraogo, JB; Piola, P; Plowe, CV; Price, RN; Rombo, L; Rosenthal, PJ; Schramm, B; Sibley, CH; Somé, AF; Stepniewska, K; Sutherland, CJ; Thwing, J; Ursing, J; Venkatesan, M; Wong, RPM; Zeynudin, A; Zongo, I | 1 |
| Emeje, M; Ezenyi, IC; Kulkarni, R; Salawu, OA | 1 |
| Effa, EE; Esu, E; Meremikwu, MM; Opie, ON; Uwaoma, A | 1 |
| Adjei, GO; Alifrangis, M; Enweronu-Laryea, CC; Goka, BQ; Khalil, I; Kurtzhals, JA; Renner, L; Rodrigues, OP; Sulley, AM | 1 |
| Buza, J; Ishengoma, DS; Lemnge, MM; Mandara, CI; Shahada, F; Shayo, A | 1 |
| Afizi, K; Fredrick, M; Kamya, MR; Lameyre, V; Lukwago, R; Talisuna, AO; Yeka, A | 1 |
| Benjamin, JM; Betuela, I; Bona, C; Davis, TM; Davis, WA; Karl, S; Kasian, B; Kattenberg, JH; Koleala, T; Laman, M; Lorry, L; Manning, L; Moore, BR; Mueller, I; Robinson, LJ; Rosanas-Urgell, A; Sambale, N; Siba, PM; Warrel, J; Yadi, G | 1 |
| Wang, FY; Wang, YB; Wei, DD; Wei, YB; Yin, B; Yu, ZH; Zhang, BG; Zhao, GH | 1 |
| Bobossi-Serengbe, G; Elowa, JB; Fioboy, R; Gody, JC; Manirakiza, A | 1 |
| Benjamin, J; Davis, TM; Ibam, C; Karl, S; Kasian, B; Koleala, T; Laman, M; Moore, BR; Mueller, I; Siba, PM; St Pierre, TG; Waltmann, A; Woodward, RC | 1 |
| Bassat, Q; Djimde, A; Hamed, K; Ogutu, B; Stricker, K | 1 |
| Djimde, AA; Hamed, K; Kuhen, K; Makanga, M | 1 |
| Duran, A; Sevim, E; Yalçın, M | 1 |
| Ansah, P; Bendel, D; Rulisa, S; Sirima, S | 1 |
| Adedeji, WA; Adewole, IF; Akinyinka, OO; Aweeka, FT; Darin, KM; Fehintola, F; Huang, L; Morse, GD; Murphy, RL; Olson, A; Parikh, S; Scarsi, KK; Taiwo, BO | 1 |
| Achan, J; Aweeka, F; Huang, L; Kajubi, R; Kiconco, S; Mwebaza, N; Mwima, MW; Nguyen, VK; Nyunt, MM; Parikh, S; Ssebuliba, J | 1 |
| Azandossessi, C; Damien, G; de Tove, YS; Kinde Gazard, D; Lawani, S; Ogouyèmi-Hounto, A; Remoue, F | 1 |
| Anvikar, AR; Arora, S; Bose, TK; Enosse, S; Gaye, O; Iyer, SS; Jalali, RK; Jha, AC; Kokolomami, J; Krudsood, S; Mohanty, R; Mohanty, S; Mwapasa, V; Ndiaye, JL; Noedl, H; Nyirenda, M; Rao, BHK; Rao, BS; Rao, D; Roy, A; Sagara, I; Saha, N; Sharma, P; Sidibe, B; Starzengruber, P; Swoboda, P; Tangpukdee, N; Thompson, R; Tiacoh, L; Toure, OA; Tshefu, AK; Valecha, N; Yumva, NN | 1 |
| Bougouma, EC; Bousema, T; Bradley, J; Diarra, A; Drakeley, C; Eziefula, AC; Gonçalves, BP; Guelbéogo, WM; Lanke, K; Nebie, I; Ouédraogo, A; Pett, H; Siaka, D; Sirima, SB; Tiono, AB | 1 |
| Batra, S; Biswas, S; Chauhan, BS; Gunjan, S; Pandey, SK; Singh, S; Singh, SK; Srivastava, K; Tripathi, R | 1 |
| de Jager, C; Hongoro, C; Longwe, H; Mutero, CM; Mwendera, C; Phiri, K | 1 |
| Chia, WN; Chotivanich, K; Goh, YS; Gruner, AC; Mayxay, M; Nosten, F; Peng, K; Preiser, P; Pukrittayakamee, S; Renia, L; Siau, A; Sriprawat, K; White, NJ | 1 |
| Ackermann, I; Aubin, F; Carn, G; Gesase, S; Lusingu, JPA; Mnkande, E; Mrango, Z; Mtoro, A; Ngocho, JS; Ogutu, B; Onyango, KO; Ouedraogo, A; Sirima, SB; Strub, N; Vanraes, J; Yaro, JB | 1 |
| Bélard, S; Damm, G; Kim, J; Kurth, F; Lingscheid, T; Mayer, B; Menner, N; Pongratz, P; Salama, A; Seehofer, D; Stegemann, MS; Steiner, F; Suttorp, N; von Bernuth, H; Zoller, T | 1 |
| Arinaitwe, E; Aweeka, FT; Bergqvist, Y; Bigira, V; Blessborn, D; Creek, DJ; Kakuru, A; McCormack, SA; Muhindo, M; Parikh, S; Sambol, NC; Sukumar, N; Tappero, JW; Tchaparian, E; Wanzira, H | 1 |
| Kong-Quee Iii, P; McKoy, MG; Pepple, DJ | 1 |
| Ahmed, I; ElMohammady, H; Jamil, M; Kakar, Q; Khan, MA; Sheikh, S; Warsame, M | 1 |
| Abdullahi, A; Affara, M; Ahouidi, AD; Coulibaly, M; D'Alessandro, U; Daniels, R; Deme, AB; Diakite, M; Diarra, A; Dieye, B; Dieye, T; Doumbia, S; Gomis, JF; Ismaela, A; Joof, F; Koita, O; Krogstad, DJ; Mbaye, A; Mbengue, B; Ndiaye, D; Ndiaye, JL; Ndiaye, M; Ndiaye, YD; Ngwa, AA; Nwakanma, D; Sangare, L; Shaffer, J; Sy, N; Volkman, SK; Welty, C; Wirth, DF | 1 |
| Kofoed, PE; Rodrigues, A; Rombo, L; Ursing, J | 1 |
| Clark, RL; DeLise, AM; Youreneff, M | 1 |
| Charunwatthana, P; Day, NP; Dondorp, AM; Faiz, MA; Fanello, CI; Ghose, A; Hanson, J; Hasan, MM; Herdman, MT; Hien, TT; Jeeyapant, A; Kingston, HW; Leopold, SJ; Maude, RJ; Ngernseng, T; Phu, NH; Plewes, K; White, NJ | 1 |
| Amran, JG; Arale, AM; Barrette, A; Hassan, AH; Hassan, AM; Jibril, AM; Mohamud, SA; Muse, AY; Nada, RA; Warsame, M; Yusuf, FE | 1 |
| Abebe, Y; Billingsley, PF; Chakravarty, S; Diallo, H; Ding, K; Dolo, A; Doumbo, O; Duffy, PE; Fay, MP; Gabriel, EE; Guindo, MA; Gunasekera, A; Healy, SA; Hoffman, SL; James, ER; Kamate, B; Katile, A; Li, M; Manoj, A; Murshedkar, T; Niangaly, A; Niaré, K; Nutman, TB; O'Connell, EM; Omaswa, F; Richie, TL; Ruben, AJ; Samake, Y; Sim, BKL; Sissoko, K; Sissoko, MS; Thera, I; Walther, M; Wong-Madden, S; Zaidi, I; Zeguime, A | 1 |
| Bukirwa, H; Dorsey, G; Kamya, MR; Lugemwa, M; Rosenthal, PJ; Rwakimari, JB; Staedke, SG; Talisuna, A; Wabwire-Mangen, F; Yeka, A | 1 |
| Adedeji, AA; Balogun, T; Bolaji, OM; Fehintola, FA; Folarin, OA; Gbotosho, GO; Happi, CT; Sowunmi, A | 1 |
| Bangali, AM; Day, NP; Dondorp, AM; Faiz, MA; Imwong, M; Kaewkungwal, J; Kamal, AT; Karim, J; Lindegardh, N; Rahman, MM; Singhasivanon, P | 1 |
| Christophel, E; Hu, XM; Lin, SG; Liu, J; Meng, F; Wang, GZ; Wang, SQ; Zeng, LH | 1 |
| Ashley, EA; Balkan, S; Bukirwa, H; Checchi, F; Dorsey, G; Guthmann, JP; Olliaro, P; Pinoges, L; Taylor, WR; Turyakira, E; Urruta, PP; van den Broek, I; van Herp, M; Zongo, I | 1 |
| Berens-Riha, N; Eshetu, T; Girma, T; Gürkov, R; Hempel, JM; Krause, E; Löscher, T; Mamo, Y; Miranda, IB; Schmidt, M | 1 |
| Coulibaly, M; Diallo, A; Diawara, SI; Dicko, A; Djimde, A; Doumbo, OK; Guindo, O; Kone, M; Maiga, H; Niambele, MB; Sagara, I; Sissoko, M | 1 |
| Davis, TM; Gomorrai, PS; Griffin, S; Ilett, KF; Karunajeewa, HA; Kotab, K; Lautu, D; Law, I; Lin, E; Mueller, I; Oa, O; Page-Sharp, M; Salman, S; Senn, M; Siba, P; Suano, P; Tarongka, N; Ura, A; Wong, R | 1 |
| Ashley, EA; Barends, M; Keereecharoen, L; Laochan, N; Lindegardh, N; McGready, R; Nosten, F; Phaiphun, L; Pimanpanarak, M; Singhasivanon, P; Tan, SO; Viladpai-Nguen, J; White, NJ; Wüstefeld, K | 1 |
| Arens, TA; de Mast, Q; Druilhe, P; Hermsen, CC; Luty, AJ; Nieman, AE; Roestenberg, M; Sauerwein, RW; Swinkels, DW; van der Ven, AJ; van Dongen-Lases, EC | 1 |
| Annerberg, A; Ashley, EA; Day, NP; Kamanikom, B; Lindegardh, N; McGready, R; Nosten, F; Pimanpanarak, M; Singhasivanon, P; Stepniewska, K; Tarning, J; White, NJ | 1 |
| Bacchieri, A; Bassat, Q; Borrmann, S; Corsi, M; D'Alessandro, U; Menéndez, C; Mulenga, M; Nabasumba, C; Nambozi, M; Piola, P; Sasi, P; Talisuna, A; Tinto, H; Ubben, D; Valéa, I | 1 |
| Arinaitwe, E; Bigira, V; Dorsey, G; Gasasira, A; Homsy, J; Kakuru, A; Kamya, MR; Katrak, S; Sandison, TG; Tappero, JW; Wanzira, H | 1 |
| de Mast, Q; Druilhe, P; Nieman, AE; Pop, G; Roestenberg, M; Sauerwein, R; Stalenhoef, A; van der Ven, A; Wiersma, J | 1 |
| Faye, B; Gaye, O; Gueye, A; Lô, AC; Ndiaye, JL; Sylla, K; Tine, R | 1 |
| Oguonu, T; Okafor, HU; Shu, EN | 1 |
| Dokomajilar, C; Greenhouse, B; Ouédraogo, JB; Rosenthal, PJ; Rouamba, N; Séré, YY; Somé, AF; Zongo, I | 1 |
| Chau, TT; Chuong, LV; Day, N; Farrar, J; Hien, TT; Mai, NT; Phu, NH; Sinh, DX; Tuan, PQ; White, NJ | 1 |
| Nosten, FH | 1 |
| Bedu-Addo, G; Bhatt, KM; Borghini-Fuhrer, I; Bustos, DG; Duparc, S; Fleckenstein, L; Gaye, O; Kayentao, K; Sesay, SS; Shin, CS; Thompson, R; Tjitra, E; Tshefu, AK | 1 |
| Kano, S | 1 |
| Akter, J; Haque, R; Khan, WA; Ley, B; Marma, AS; Noedl, H; Starzengruber, P; Swoboda, P; Thriemer, K; Vossen, MG | 1 |
| Annerberg, A; Ashton, M; Björkman, A; Dahlström, S; Färnert, A; Gil, P; Hietala, SF; Lindegårdh, N; Mårtensson, A; Ngasala, B; Premji, Z | 1 |
| Day, NP; Hanpithakpong, W; Kamanikom, B; Lindegardh, N; Singhasivanon, P; White, NJ | 1 |
| Cochupanachimootil, J; Harris, P; Norton, R; Price, S; Senthuran, S | 1 |
| Abdulla, S; Bassat, Q; Borrmann, S; Djimdé, AA; Lefèvre, G; Lyimo, J; Mandomando, I; Tekete, M | 1 |
| Faye, B; Faye, O; Kane, D; Kassi, KF; Kiki Barro, CP; Kone, M; Kuete, T; Menan, H; N'diaye, JL; Oga, AS; Same-Ekobo, A; Tine, R; Vicky, AM; Yavo, W | 1 |
| Davis, TM; Hwaiwhanje, I; Karunajeewa, HA; Laman, M; Manning, L; Morep, N; Mueller, I; Page-Sharp, M; Salman, S; Siba, P | 1 |
| Caroli, A; Lepore, R; Raimondo, D; Simeoni, S; Tramontano, A; Via, A | 1 |
| Denholm, J; Shortt, J; Smith, A; Spelman, D | 1 |
| Bashraheil, M; Bassat, Q; González, R; Kipkeu, C; Lefèvre, G; Lyimo, J; Machevo, S; Maiga, H; Mårtensson, A; Menéndez, C; Nahum, A; Nwaiwu, O; Ogutu, B; Ouma, P; Ubben, D; Walter, V | 1 |
| Chaudhry, AA; Khan, A; Khan, U | 1 |
| Kopel, E; Marhoom, E; Schwartz, E; Sidi, Y | 1 |
| Khairnar, K; Krishna, S; Lau, R; Lepore, R; Pillai, DR; Staines, HM; Via, A | 1 |
| Shanbag, P; Zaki, SA | 1 |
| Day, NP; Dhorda, M; Guerin, PJ; Kloprogge, F; Lindegardh, N; Muwanga, S; Nosten, F; Nuengchamnong, N; Piola, P; Tarning, J; Turyakira, E; White, NJ | 1 |
| Kusriastuti, R; Surya, A | 1 |
| Cabezas-Fernández, MT; Giménez-López, MJ; Muñoz-Vilches, MJ; Salas-Coronas, J | 1 |
| Córdoba, F; De la Hoz Restrepo, F; Porras Ramírez, A; Rico Mendoza, A; Rojas, DP | 1 |
| Balbiano, R; Calleri, G; Caramello, P | 1 |
| Achan, J; D'Alessandro, U; Talisuna, AO; Tibenderana, J; Yeka, A | 1 |
| Bhagyabati Devi, S; Singh, MA; Singh, NB; Singh, TB | 1 |
| Garner, P; Omari, A | 3 |
| Elie, N; Gao, YQ; Huang, JR | 1 |
| White, NJ | 2 |
| Camus, D; Delhaes, L; Dutoit, E; Frealle, E | 1 |
| Hatabu, T; Ishizaki, A; Kano, S; Kikuchi, Y; Oka, S; Yasuoka, A | 1 |
| Bricaire, F; Danis, M | 1 |
| Adam, I; Aelbasit, IA; Elbashir, MI; Idris, HM; Mohamed-Ali, AA | 1 |
| Kumar, A; Pant, P; Prakash, S; Sharma, P | 1 |
| Garner, P; Omari, AA; Preston, C | 1 |
| Bethell, D; Blakemore, WF; Cavanagh, JB; Day, NP; Dayan, A; Hien, TT; Mai, NT; Medana, I; Phu, NH; Turner, GD; Weller, RO; White, NJ | 1 |
| Brittenham, GM; Gourdeuk, VR; Krudsood, S; Looareesuwan, S; Phomrattanaprapin, W; Silachamroon, U; Treeprasertsuk, S; Vannaphan, S; Wilairatana, P | 1 |
| Brittenham, GM; Chalermrut, K; Kano, S; Krudsood, S; Looareesuwan, S; Pengruksa, C; Silachamroon, U; Srivilairit, S; Treeprasertsuk, S | 1 |
| Newton, PN; Pukrittayakamee, S; Rasameesoraj, M; Silamut, K; Siriyanonda, D; Suputtamongkol, Y; Teja-Isavadharm, P; White, NJ | 1 |
| Aarons, L; Edwards, G; Kokwaro, GO; Majid, O; Marsh, K; Mithwani, S; Mohamed, S; Muchohi, S; Watkins, W | 1 |
| Amklad, I; Looareesuwan, S; Rojanawatsirivej, C; Vijaykadga, S; Wilairatna, P | 1 |
| Kumar, S | 1 |
| Barihuta, T; Barutwanayo, M; Bosman, A; Ciza, A; Delacollette, C; Kamana, J; Karenzo, J; Mizero, L; Moyou-Somo, R; Nahimana, A; Ndaruhutse, J; Ndayiragije, A; Niyungeko, D; Niyungeko, E; Nyarushatsi, JP; Ringwald, P | 1 |
| Adam, I; Elansari, E; Elbashir, MI; Elwasila, E; Mohammed Ali, DA | 1 |
| Adjuik, M; Afful, TM; Anto, F; Anyorigiya, T; Atuguba, F; Hodgson, A; Oduro, AR; Owusu-Agyei, S | 1 |
| Bisoffi, Z; Depoortere, E; Guthmann, JP; Salvador, ET; Stivanello, E | 1 |
| Dietz, K; English, M; Marsh, K; Muller, I; Smith, T; Vounatsou, P | 1 |
| Wernsdorfer, WH | 1 |
| Annerberg, A; Barends, M; Keola, S; Khanthavong, M; Lindegårdh, N; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; White, NJ; Yapom, R | 1 |
| Ariey, F; Baur, F; Lepere, JF; Macarry, A; Rabarijaona, LP; Raharimalala, LA; Randrianarivelojosia, M; Receveur, MC; Robert, V; Roussin, C; Roussin, JM; Tall, A | 1 |
| Agus, C; Chiswell, GM; Chuong, LV; Davis, TM; Farrar, J; Hien, TT; Ilett, KF; Phu, NH; Sinh, DX; White, NJ | 1 |
| Annerberg, A; Christophel, EM; Dittrich, S; Jelinek, T; Lindegardh, N; Monti, F; Phetsouvanh, R; Phompida, S; Stohrer, JM; Thongpaseuth, V; Vanisaveth, V | 1 |
| Bajunirwe, F; Biraro, S; Checchi, F; Fogg, C; Guthmann, JP; Kiguli, J; Kyomugisha, A; Musabe, J; Namiiro, P; Piola, P | 1 |
| Björkman, A; Gil, JP; Mårtensson, A; Msellem, M; Obondo, C; Sisowath, C; Strömberg, J | 1 |
| Shen, WJ; Thiero, M | 1 |
| Bray, PG; Horrocks, P; Makanga, M; Ward, SA | 1 |
| Bangali, AM; Barends, M; Das, S; Faiz, AM; Kamal, M; Liem, L; Maung, UA; Peters, A; Rahman, M; Rahman, MR; van den Broek, IV | 1 |
| Garner, P; Jones, K; Taylor-Robinson, D | 1 |
| Hastings, IM; Ward, SA | 1 |
| Ali, AS; Björkman, A; Gil, JP; Mårtensson, A; Montgomery, SM; Msellem, MI; Olliaro, P; Sisowath, C; Strömberg, J | 1 |
| Ashley, EA; Brockman, A; Hutagalung, R; Jelinek, T; McGready, R; Nosten, FH; Paiphun, L; Singhasivanon, P; Thwai, KL; White, NJ | 1 |
| Allen, E; Barnes, KI; Bredenkamp, B; Dlamini, SS; Durrheim, DN; Jackson, A; Little, F; Mehta, U; Mthembu, DJ; Sharp, BL; Tsoka, J; White, NJ | 1 |
| Argaw, D; Babaniyi, O; Jima, D; Kebede, A; Medhin, A; Tesfaye, G | 1 |
| Alecrim, MG; Alecrim, WD; Boulos, M; Cardoso, BS; Lacerda, MV; Mourão, MP; Padilha, A | 1 |
| Ahmed, OA; Elamin, SB; Eltaib, EH; Malik, EM; Mohamed, AO | 1 |
| Adam, I; Kheir, MM; Mohammed-Ali, AR | 1 |
| Chiswell, GM; Dabod, E; Davis, TM; Hamzah, J; Ilett, KF; Karunajeewa, HA; Lorry, K; Page-Sharp, M; Reeder, J | 1 |
| Adedeji, AA; Bamgboye, AE; Bolaji, OM; Fateye, BA; Gbotosho, GO; Happi, TC; Oduola, AM; Sowunmi, A | 1 |
| Balkan, S; Checchi, F; Guerin, PJ; Guthmann, JP; Pinoges, L; Rolland, E | 1 |
| Anderson, TJ; Brockman, A; Hutagalung, R; Krishna, S; Nair, S; Nash, D; Nosten, F; Price, RN; Singhasivanon, P; Uhlemann, AC; van Vugt, M; White, NJ | 1 |
| Alaribe, A; Ejemot, R; Ekenjoku, J; Ezedinachi, E; Meremikwu, M; Nwachukwu, C; Ordu, D; Oyo-Ita, A | 1 |
| Andriano, K; De Palacios, PI; Falade, C; Hunt, P; Karbwang, J; Makanga, M; Mueller, EA; Premji, Z | 1 |
| Balkan, S; Cohuet, S; Fortes, F; Francis, M; Guthmann, JP; Kiguli, J; Kyomuhendo, J; Mulemba, M; Noël, F; Rigutto, C; Saraiva, N | 1 |
| Babigumira, J; Bajunirwe, F; Biraro, S; Checchi, F; Ferradini, L; Fogg, C; Grandesso, F; Guthmann, JP; Kigozi, I; Kiguli, J; Kyomuhendo, J; Piola, P; Ruzagira, E; Taylor, WR | 1 |
| Ahmed, ES; Elamin, SB; Elhassan, AH; Elmardi, KA; Malik, EM; Mannan, AA; Mohamed, TA; Mowien, RM | 1 |
| Toovey, S | 1 |
| Chalwe, V; Chilengi, R; D'Alessandro, U; Dujardin, JC; Moerman, F; Mulenga, M; Mwananyanda, L; Van Overmeir, C; VangGeertruyden, JP | 1 |
| Chanda, P; Hawela, M; Kango, M; Sipilanyambe, N | 1 |
| Chalwe, V; Chilengi, R; Colebunders, R; D'Alessandro, U; Dujardin, JC; Kasongo, W; Kestens, L; Moerman, F; Mulenga, M; Mwananyanda, L; Van Geertruyden, JP; Van Overmeir, C | 1 |
| Chappuis, F; Jackson, Y; Loutan, L; Taylor, W | 1 |
| Agbéko, F; Akpako, P; Atakouma, DY; Badayodi, A; Gbadoé, AD; Géraldo, A; Guédénon, J; Lawson-Evi, K | 1 |
| Dicko, A; Djimde, A; Doumbo, OK; Fofana, M; Guindo, O; Jansen, HF; Kone, M; Ouattara, A; Sagara, I; Sissoko, M; Sogoba, M; Thera, MA; Tolo, Y | 1 |
| Ashley, EA; La, Y; Lindegardh, N; McGready, R; Nosten, F; Singhasivanon, P; Stepniewska, K; White, NJ | 1 |
| Al Attas, S; Balasegaram, M; Guthmann, JP; Kitz, C; Libama, F; van den Broek, I | 1 |
| Kokwaro, G; Mwai, L; Nzila, A | 1 |
| Ahmed, J; Hallett, RL; Humphreys, GS; Merinopoulos, I; Mutabingwa, TK; Sutherland, CJ; Whitty, CJ | 1 |
| Atemnkeng, MA; De Cock, K; Plaizier-Vercammen, J | 1 |
| Ayede, I; Dada-Adegbola, HO; Fadero, FF; Falade, AG; Falade, CO; Gbotosho, GO; Happi, CT; Oduola, AM; Salako, LA | 1 |
| Cravo, P; do Rosário, VE; Ferreira, C; Ferreira, ID; Lopes, D; Martinelli, A | 1 |
| Abdalli Mari, M; Ariey, F; Astafieva-Djaza, M; Gayibor, AH; Hafidhou, M; Moussa, M; Oumadi, A; Randrianarivelojosia, M; Ringwald, P; Said Ahmed, B; Said Ankili, A; Silai, R | 1 |
| Checkley, AM; Whitty, CJ | 1 |
| Dokomajilar, C; Dorsey, G; Joloba, M; Nsobya, SL; Rosenthal, PJ | 1 |
| Dieng, Y; Faye, B; Faye, O; Gaye, O; Ndiaye, D; Ndiaye, JL | 1 |
| Berger, P; den, HJ; van Wout, JW; Visser, LG | 1 |
| Abdulla, S; Kabanywanyi, AM; Mandike, R; Mugittu, K; Mwita, A; Sumari, D | 1 |
| Cravo, P; do Carmo, EL; do Rosário, VE; Ferreira, ID; Martinelli, A; Póvoa, MM; Rodrigues, LA | 1 |
| Ademowo, OG; Falade, CO; Ladipo, SM; Ogundele, AO; Yusuf, BO | 1 |
| Ademowo, OG; Adewunmi, CO; Agboola, OI; Daniyan, OM; Gbolade, AA; Iwalewa, EO; Nneji, C; Omisore, NO | 1 |
| Fernández, FM; Green, MD; Keoluangkhot, V; Mayxay, M; Newton, PN; Nyadong, L | 1 |
| Bray, PG; Lowe, B; Marsh, K; Murphy, S; Peshu, N; Watkins, WM; Winstanley, PA | 1 |
| Turner, GD | 1 |
| Harinasuta, T; Karbwang, J; Na-Bangchang, K; Thanavibul, A; Wattanakoon, Y | 1 |
| Harinasuta, T; Karbwang, J; Mungthin, M; Na-Bangchang, K; Thanavibul, A | 1 |
| Adio, R; Oduola, AM; Omokhodion, SJ; Salako, LA; Sowunmi, A; Walker, O | 1 |
| Looareesuwan, S | 1 |
| Hien, TT | 1 |
| Edwards, G; Karbwang, J; Na Bangchang, K; Sukontason, K; Thanavibul, A; Thomas, CG; Ward, SA | 1 |
| Kano, S; Kawai, S; Suzuki, M | 1 |
| Bunnag, D; Chitamas, S; Harinasuta, T; Karbwang, J | 1 |
| Ager, AL; Canfield, CJ; Heiffer, MH; Klayman, DL; Kyle, DE; Milhous, WK; Rossan, RN; Schuster, BG; Shmuklarsky, MJ; Tang, DB | 1 |
| Ambroise-Thomas, P | 1 |
| Angus, B; Bates, I; Krishna, S; Kyle, DE; Pipitaporn, B; Pukrittayakamee, S; Suputtamongkol, Y; Udomsangpetch, R; White, NJ | 1 |
| Watkins, WM | 1 |
| Dufillot, D; Duong, T; Guiguen, C; Guiyedi, V; Koko, J; Kombila, M; Richard-Lenoble, D | 1 |
| Hoffman, SL | 1 |
| Day, NP; Dinh, XS; Ha, V; Ly, VC; Nguyen, HP; Nguyen, TH; Peto, TE; Pham, PL; Tran, TH; Waller, D; White, NJ | 1 |
| Wise, J | 1 |
| Ilesanmi, AO; Oduola, AM; Salako, LA; Sowunmi, A | 1 |
| Banmairuroi, V; Karbwang, J; Molunto, P; Na-Bangchang, K; Thanavibul, A | 1 |
| Davis, TM; Johnston, WA; Manning, LS; Skinner, TS | 1 |
| Ditta-in, M; Harinasuta, T; Karbwang, J; Laothavorn, P; Na-Bangchang, K; Thanavibul, A | 1 |
| Doyon, F; Gachot, B; Hill, C | 1 |
| Newmark, A | 1 |
| Kanda, T; Karbwang, J; Na-Bangchang, K; Suprakob, K; Tan-ariya, P; Thanavibul, A; Tipwangso, P | 1 |
| Oduola, AM; Sowunmi, A | 2 |
| Garg, RK | 1 |
| Ibrahim, M; Kanda, T; Karbwang, J; Na-Bangchang, K; Suprakob, K; Thanavibul, A; Tipawangso, P; Wattanagoon, Y | 1 |
| Congpuong, K; Karbwang, J; Na-Bangchang, K; Sirichaisinthop, J; Suprakorb, K | 1 |
| Kyle, DE; Looareesuwan, S; Pitisuttithum, P; Vanijanonta, S; Viravan, C; Wilairatana, P | 1 |
| Odulola, AM; Sowunmi, A | 1 |
| Breton, G; Le Bras, M; Nicolas, X | 1 |
| Falade, CO; Fehintola, FA; Kyle, DE; Makler, MT; Milhous, WK; Oduola, AM; Ogundahunsi, OA; Omitowoju, GO; Piper, RC; Schuster, BG; Sowunmi, A | 1 |
| Dufillot, D; Duong, TH; Ferrer, A; Guiguen, C; Guiyedi, V; Koko, J; Kombila, M; Richard-Lenoble, D | 1 |
| Brockman, A; Gathmann, I; Gemperli, B; Looareesuwan, S; Luxemburger, C; Nosten, F; Royce, C; Slight, T; van Vugt, M; White, NJ | 1 |
| Doury, JC; Fusai, T; Pradines, B; Rogier, C; Tall, A; Trape, JF | 1 |
| Chanyakhun, P; Palananth, C; Rooney, W; Sirichaisinthop, J; Thimasarn, K | 1 |
| Bunnag, D; Karbwang, J; Laothavorn, P; Na-Bangchang, K; Rimchala, W; Sukontason, K; Thiha, T | 1 |
| Congpuong, K; Karbwang, J; Molunto, P; Na-Bangchang, K; Thanavibul, A; Wattanakoon, Y | 1 |
| Bojang, K; Doherty, T; Gathmann, I; Gemperli, B; Greenwood, B; Haywood, M; Jaffar, S; Jones, P; McAdam, K; Obaro, S; Pinder, M; Royce, C; Snounou, G; von Seidlein, L | 1 |
| Karbwang, J; Molunto, P; Na-Bangchang, K; Thanavibul, A | 1 |
| Black, J; Kevau, I; Lalloo, DG; Laurenson, IF; Naraqi, S; Nwokolo, N; Saweri, A; Seaton, RA; Trevett, AJ; Warrell, DA; Wembri, JP | 1 |
| Bunnag, D; Harinasuta, T; Kanda, T; Karbwang, J; Pungpak, S; Thimasarn, K | 1 |
| Bhattacharya, PC; Pai-dhungat, AJ; Patel, K | 1 |
| Abdulla, S; Beck, HP; Gathmann, I; Hatz, C; Kibatala, P; Mull, R; Royce, C; Schellenberg, D; Tanner, M | 1 |
| Harinasuta, T; Karbwang, J; Na-Bangchang, K; Rimchala, W; Sukontason, K; Tin, T | 1 |
| Doury, JC; Kombila, M; Lebeau, C; Mabika Mamfoumbi, M; Mourou Mbina, JR; Owono Medang, M; Parzy, D; Pradines, B | 1 |
| Brockman, A; Chongsuphajaisiddhi, T; Luxemburger, C; Nosten, F; Phaipun, L; Price, R; van Vugt, M; White, N | 1 |
| Chalermrut, K; Chokejindachai, W; Gathmann, I; Gemperli, B; Looareesuwan, S; Royce, C; Wernsdorfer, W; Wilairatana, P | 1 |
| Li, Y; Wu, YL | 1 |
| Mull, R; Skelton-Stroud, P | 1 |
| Helenport, JP; Roche, G | 1 |
| Chongsuphajaisiddhi, T; Kham, A; Luxemburger, C; McGready, R; Nosten, F; Phaipun, L; Price, R; Simpson, J; ter Kuile, F; van Vugt, M; White, NJ | 1 |
| Cheng-Qi, S; Mull, R; Qing, JX; van Agtmael, MA; van Boxtel, CJ | 1 |
| Danis, M; Duparc, S; Fargier, JJ; Hounsinou, C; Louis, FJ; Ringwald, P | 1 |
| Farkad, E; Karbwang, J; Mull, R; Na-Bangchang, K; Tasanor, U; Thanavibul, A | 1 |
| Ezzet, F; Gathmann, I; Looareesuwan, S; Nosten, F; van Vugt, M; White, NJ; Wilairatana, P | 1 |
| Ezzet, F; Looareesuwan, S; Nosten, F; van Vugt, M; White, NJ | 1 |
| Angus, BJ; Htoo, SE; Looareesuwan, S; Mann, C; Nosten, F; Poletto, C; Price, RN; Simpson, JA; Van Vugt, M; White, NJ | 1 |
| Fusai, T; Mosnier, J; Parzy, D; Pradines, B; Rogier, C; Spiegel, A; Tall, A; Trape, JF | 1 |
| Congpuong, K; Karbwang, J; Na-Bangchang, K; Sirichaisinthop, J; Tippawangkosol, P; Ubalee, R | 1 |
| Bhandari, S; Saxena, GN; Sharma, P; Sharma, UB; Swarup, D; Tuteja, R | 1 |
| Karbwang, J; Na-Bangchang, K; Tanariya, P; Tippawangkoso, P; Wernsdorfer, WH | 1 |
| Gogtay, NJ; Kadam, VS; Kamtekar, KD; Kanbur, A; Karnad, DR; Kshirsagar, NA | 1 |
| Angus, B; Keeratithakul, D; Newton, PN; Pukrittayakamee, S; Rasameesoraj, M; Suputtamongkol, Y; Teja-Isavadharm, P; White, NJ | 1 |
| Arya, SC | 1 |
| Krudsood, S; Looareesuwan, S; Lugt, ChB; Oosterhuis, B; Peeters, PA; Peggins, JO; Schilizzi, BM; Sollie, FA; Wilairatana, P | 1 |
| Bunnag, D; Harinasuta, T; Karbwang, J | 1 |
| Auprayoon, P; Bunnag, D; Harinasuta, T; Karbwang, J; Namsiripongpun, W; Rimchala, W; Sukontason, K; Tin, T; Tumsupapong, S | 1 |
| Lalloo, D; Trevett, A | 1 |
| Brewster, D; Chapman, D; Crawley, J; Greenwood, BM; Nosten, F; Waller, D; White, NJ | 1 |
| Bangchang, KN; Bunnag, D; Chongsuphajaisiddhi, T; Harinasuta, T; Karbwang, J; Thanavibul, A | 1 |
| Hla, KK; Shwe, T | 1 |
| Chandiwana, S; Mharakurwa, S; Mutetwa, S; Neill, P; Simooya, O; Stein, M | 1 |
| Bunnag, D; Harinasuta, T; Karbwang, J; Looareesuwan, S; Viravan, C | 1 |
37 review(s) available for artemether and Malaria, Falciparum
| Article | Year |
|---|---|
Using genetic methods to define the targets of compounds with antimalarial activity.
Topics: Animals; Anopheles; Antimalarials; Drug Resistance; Genetic Association Studies; Genome, Protozoan; Humans; Malaria, Falciparum; Molecular Targeted Therapy; Plasmodium falciparum | 2013 |
Comparative effect of dihydroartemisinin-piperaquine and artemether-lumefantrine on gametocyte clearance and haemoglobin recovery in children with uncomplicated Plasmodium falciparum malaria in Africa: a systematic review and meta-analysis of randomized c
Topics: Africa; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Fluorenes; Hemoglobins; Humans; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Randomized Controlled Trials as Topic | 2021 |
Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis.
Topics: Africa South of the Sahara; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Humans; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines | 2022 |
Drug-Drug Interactions of Artemisinin-Based Combination Therapies in Malaria Treatment: A Narrative Review of the Literature.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum | 2022 |
Comparative efficacy and safety of the artemisinin derivatives compared to quinine for treating severe malaria in children and adults: A systematic update of literature and network meta-analysis.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Humans; Malaria, Cerebral; Malaria, Falciparum; Network Meta-Analysis; Quinine | 2022 |
Pregnancy outcomes after first-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: a systematic review and individual patient data meta-analysis.
Topics: Abortion, Spontaneous; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Ethanolamines; Female; Humans; Malaria; Malaria, Falciparum; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Prospective Studies; Quinine; Stillbirth | 2023 |
The effect and control of malaria in pregnancy and lactating women in the Asia-Pacific region.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Asia; Female; Humans; Lactation; Malaria; Malaria, Falciparum; Pregnancy | 2023 |
Efficacy of Single-Dose Primaquine With Artemisinin Combination Therapy on Plasmodium falciparum Gametocytes and Transmission: An Individual Patient Meta-Analysis.
Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Humans; Malaria, Falciparum; Plasmodium falciparum; Primaquine | 2022 |
The Relative Effects of Artemether-lumefantrine and Non-artemisinin Antimalarials on Gametocyte Carriage and Transmission of Plasmodium falciparum: A Systematic Review and Meta-analysis.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Culicidae; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Randomized Controlled Trials as Topic | 2017 |
Artemether for severe malaria.
Topics: Adolescent; Adult; Africa; Age Factors; Antimalarials; Artemether; Artesunate; Asia; Child; Child, Preschool; Coma; Fever; Humans; Infant; Injections, Intramuscular; Malaria, Cerebral; Malaria, Falciparum; Oceania; Quinine; Randomized Controlled Trials as Topic; Treatment Outcome | 2019 |
Artemether and lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.
Topics: Africa South of the Sahara; Antimalarials; Artemether; Artemisinins; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Practice Guidelines as Topic; Treatment Outcome | 2013 |
Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Directly Observed Therapy; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Quinolines | 2013 |
A review of dihydroartemisinin as another gift from traditional Chinese medicine not only for malaria control but also for schistosomiasis control.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Drugs, Chinese Herbal; Female; Malaria, Falciparum; Mice; Praziquantel; Schistosomiasis japonica; Schistosomicides | 2014 |
Artemether for severe malaria.
Topics: Adolescent; Adult; Africa; Antimalarials; Artemether; Artemisinins; Artesunate; Asia; Child; Child, Preschool; Humans; Infant; Injections, Intramuscular; Malaria, Cerebral; Malaria, Falciparum; Oceania; Quinine; Randomized Controlled Trials as Topic | 2014 |
Tailoring a Pediatric Formulation of Artemether-Lumefantrine for Treatment of Plasmodium falciparum Malaria.
Topics: Antimalarials; Artemether; Artemisinins; Chemistry, Pharmaceutical; Clinical Trials, Phase III as Topic; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Randomized Controlled Trials as Topic; Tablets | 2015 |
The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine.
Topics: Africa South of the Sahara; Antimalarials; Artemether; Artemisinins; Asia; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum | 2015 |
Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data.
Topics: Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Recurrence; Treatment Failure | 2015 |
Artemisinin-based combination therapies and their introduction in Japan.
Topics: Animals; Antimalarials; Artemether; Artemisia annua; Artemisinins; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Japan; Lumefantrine; Malaria, Cerebral; Malaria, Falciparum; Mefloquine; Plasmodium falciparum | 2010 |
Malaria in endemic areas.
Topics: Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Drug Administration Routes; Endemic Diseases; Humans; Malaria, Falciparum; Quinine; Randomized Controlled Trials as Topic; Sesquiterpenes; Treatment Outcome | 2002 |
The new drug combinations: their place in the treatment of uncomplicated Plasmodium falciparum malaria.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Atovaquone; Drug Resistance, Multiple; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Naphthoquinones; Proguanil; Sesquiterpenes | 2003 |
Artemether-lumefantrine for treating uncomplicated falciparum malaria.
Topics: Antimalarials; Artemether; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Randomized Controlled Trials as Topic; Sesquiterpenes | 2003 |
Malaria in endemic areas.
Topics: Antimalarials; Artemether; Artemisinins; Blood Transfusion; Chloroquine; Deferoxamine; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2003 |
Coartemether (artemether and lumefantrine): an oral antimalarial drug.
Topics: Administration, Oral; Animals; Antimalarials; Artemether; Artemisinins; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Sesquiterpenes | 2004 |
Malaria: severe, life threatening.
Topics: Antimalarials; Artemether; Artemisinins; Blood Transfusion; Humans; Malaria; Malaria, Falciparum; Quinine; Sesquiterpenes | 2004 |
Malaria: uncomplicated, caused by Plasmodium falciparum.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Proguanil; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2005 |
Efficacy and safety of the six-dose regimen of artemether-lumefantrine in pediatrics with uncomplicated Plasmodium falciparum malaria: a pooled analysis of individual patient data.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Body Weight; Child; Child, Preschool; Clinical Trials as Topic; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Ethanolamines; Female; Fever; Fluorenes; Humans; Infant; Life Cycle Stages; Lumefantrine; Malaria, Falciparum; Male; Time Factors | 2006 |
Artemether/lumefantrine in the treatment of uncomplicated falciparum malaria.
Topics: Artemether; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum | 2007 |
Artesunate, artemether or quinine in severe Plasmodium falciparum malaria?
Topics: Animals; Artemether; Artemisinins; Artesunate; Humans; Malaria, Falciparum; Quinine; Sesquiterpenes | 2007 |
Overview of clinical studies on artemisinin derivatives in Thailand.
Topics: Antimalarials; Antiprotozoal Agents; Artemether; Artemisinins; Artesunate; Clinical Trials as Topic; Drug Resistance; Humans; Malaria, Falciparum; Sesquiterpenes; Thailand | 1994 |
An overview of the clinical use of artemisinin and its derivatives in the treatment of falciparum malaria in Viet Nam.
Topics: Adolescent; Adult; Antimalarials; Antiprotozoal Agents; Artemether; Artemisinins; Artesunate; Clinical Trials as Topic; Double-Blind Method; Drug Resistance; Humans; Malaria, Falciparum; Middle Aged; Sesquiterpenes; Vietnam | 1994 |
[The role of qinghaosu derivatives in the treatment of malaria in 1995].
Topics: Antimalarials; Artemether; Artemisinins; Clinical Trials as Topic; Drug Resistance; Forecasting; Humans; Malaria, Falciparum; Sesquiterpenes; Treatment Outcome | 1995 |
Pharmacology and pharmacokinetics of new antimalarials.
Topics: Africa; Antimalarials; Artemether; Artemisinins; Drug Costs; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Phenanthrenes; Sesquiterpenes; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
How Chinese scientists discovered qinghaosu (artemisinin) and developed its derivatives? What are the future perspectives?
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Drug Evaluation; Drug Resistance; Forecasting; Humans; Malaria, Falciparum; Medicine, Chinese Traditional; Sesquiterpenes | 1998 |
Positioning, labelling, and medical information control of co-artemether tablets (CPG 56697): a fixed novel combination of artemether and benflumetol. Novartis Co-Artemether International Development Team.
Topics: Administration, Oral; Adolescent; Adult; Artemether; Artemisinins; Child; Child, Preschool; China; Drug Combinations; Drug Evaluation, Preclinical; Drug Industry; Drug Information Services; Drug Labeling; Drug Resistance; Ethanolamines; Fluorenes; Humans; International Cooperation; Lumefantrine; Malaria, Falciparum; Sesquiterpenes; Switzerland; Time Factors | 1998 |
What have been the strategies for the registration, positioning and control of medical information for intramuscular artemether?
Topics: Antimalarials; Artemether; Artemisinins; China; Drug and Narcotic Control; Drug Industry; Drug Information Services; Drugs, Essential; France; Humans; Injections, Intramuscular; International Cooperation; Malaria, Falciparum; Registries; Sesquiterpenes; World Health Organization | 1998 |
Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives.
Topics: Acute Disease; Antimalarials; Artemether; Artemisinins; Artesunate; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Sesquiterpenes | 1999 |
A new look at an old drug: artemesinin and qinghaosu.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Humans; Malaria, Cerebral; Malaria, Falciparum; Sesquiterpenes | 1992 |
149 trial(s) available for artemether and Malaria, Falciparum
| Article | Year |
|---|---|
Joint modelling of multivariate longitudinal clinical laboratory safety outcomes, concomitant medication and clinical adverse events: application to artemisinin-based treatment during pregnancy clinical trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Female; Humans; Laboratories; Malaria, Falciparum; Pregnancy | 2021 |
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Coadministered Ruxolitinib and Artemether-Lumefantrine in Healthy Adults.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Nitriles; Pyrazoles; Pyrimidines; Single-Blind Method; Young Adult | 2022 |
Effectiveness and safety of artesunate-amodiaquine versus artemether-lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6-120 months in Yaoundé, Cameroon: a randomized trial.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Cameroon; Child; Drug Combinations; Ethanolamines; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Treatment Outcome | 2022 |
Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria; Malaria, Falciparum; Male; Plasmodium falciparum; Recurrence; Vomiting | 2022 |
Artemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Grande Comore island: an open-label, non-randomised controlled trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines | 2022 |
The Impact of Extended Treatment With Artemether-lumefantrine on Antimalarial Exposure and Reinfection Risks in Ugandan Children With Uncomplicated Malaria: A Randomized Controlled Trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Malaria, Falciparum; Parasitemia; Prospective Studies; Reinfection; Uganda | 2023 |
Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Cambodia; Chemoprevention; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum | 2023 |
Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Chemoprevention; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum | 2022 |
Effectiveness of antimalarial drug combinations in treating concomitant urogenital schistosomiasis in malaria patients in Lambaréné, Gabon: A non-randomised event-monitoring study.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Drug Combinations; Ethanolamines; Gabon; Humans; Malaria; Malaria, Falciparum; Schistosomiasis haematobia | 2022 |
Comparative effect of artemether-lumefantrine and artesunate-amodiaquine on gametocyte clearance in children with uncomplicated Plasmodium falciparum malaria in Madagascar.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Child, Preschool; Drug Combinations; Ethanolamines; Humans; Infant; Madagascar; Malaria, Falciparum; Plasmodium falciparum | 2022 |
Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Ethiopia; Humans; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Plasmodium vivax | 2022 |
Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, n
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Democratic Republic of the Congo; Female; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Primaquine; Uganda; World Health Organization | 2023 |
Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; HIV Infections; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malawi; Treatment Outcome | 2023 |
Ultra-short course, high-dose primaquine to prevent Plasmodium vivax infection following uncomplicated pediatric malaria: A randomized, open-label, non-inferiority trial of early versus delayed treatment.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Parasitemia; Plasmodium vivax; Primaquine; Time-to-Treatment | 2023 |
Therapeutic response to artemisinin combination therapies among individuals with Plasmodium falciparum single infection vs mixed Plasmodium species infections: a retrospective posthoc analysis in Kisumu County, western Kenya.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Humans; Kenya; Malaria; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Reinfection; Retrospective Studies | 2023 |
Efficacy and safety of pyronaridine-artesunate versus artemether-lumefantrine in the treatment of acute uncomplicated malaria in children in South-West Nigeria: an open-labelled randomized controlled trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Retrospective Studies; Treatment Outcome | 2023 |
Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Child; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Plasmodium falciparum; Treatment Outcome | 2023 |
Efficacy and safety of pyronaridine-artesunate (PYRAMAX) for the treatment of
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Clinical Trials, Phase III as Topic; Drug Combinations; Female; Humans; Infant; Malaria; Malaria, Falciparum; Pregnancy; Pregnant Women; Randomized Controlled Trials as Topic; Sub-Saharan African People; Treatment Outcome | 2023 |
Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placebo.
Topics: alpha-Thalassemia; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Child, Preschool; Female; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Primaquine | 2023 |
Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Australia; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Parasitemia; Plasmodium falciparum; Plasmodium vivax; Primaquine | 2023 |
A Randomized Controlled Trial of Three- versus Five-Day Artemether-Lumefantrine Regimens for Treatment of Uncomplicated Plasmodium falciparum Malaria in Pregnancy in Africa.
Topics: Adult; Africa; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Female; Humans; Malaria, Falciparum; Pregnancy; Young Adult | 2020 |
Randomized Controlled Trial of the Electrocardiographic Effects of Four Antimalarials for Pregnant Women with Uncomplicated Malaria on the Thailand-Myanmar Border.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Therapy, Combination; Electrocardiography; Female; Humans; Malaria; Malaria, Falciparum; Myanmar; Pregnancy; Pregnant Women; Quinolines; Thailand | 2021 |
Efficacy and safety of artesuante-amodiaquine and artemether lumefantrine, the first line malaria treatment in six sentinel's sites of Côte d'Ivoire, West Africa.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Cote d'Ivoire; Drug Combinations; Ethanolamines; Fluorenes; Humans; Infant; Malaria; Malaria, Falciparum; Treatment Outcome | 2020 |
A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Malaria; Malaria, Falciparum; Mefloquine; Myanmar; Pregnancy; Premature Birth; Quinolines; Thailand | 2021 |
High Prevalence of Plasmodium falciparum K13 Mutations in Rwanda Is Associated With Slow Parasite Clearance After Treatment With Artemether-Lumefantrine.
Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Resistance; Gabon; Humans; Malaria, Falciparum; Mutation; Parasites; Plasmodium falciparum; Prevalence; Protozoan Proteins; Rwanda | 2022 |
Study protocol: an open-label individually randomised controlled trial to assess the efficacy of artemether-lumefantrine prophylaxis for malaria among forest goers in Cambodia.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cambodia; Forests; Humans; Malaria; Malaria, Falciparum; Randomized Controlled Trials as Topic; Treatment Outcome | 2021 |
Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria.
Topics: Adult; Africa South of the Sahara; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Ethanolamines; Fluorenes; Humans; Indoles; Malaria, Falciparum; Plasmodium falciparum; Spiro Compounds; Treatment Outcome | 2022 |
Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.
Topics: Alleles; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Democratic Republic of the Congo; Drug Combinations; Ethanolamines; Fluorenes; Haplotypes; Humans; Lumefantrine; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Uganda | 2018 |
Effectiveness of artemether/lumefantrine for the treatment of uncomplicated Plasmodium vivax and P. falciparum malaria in young children in Papua New Guinea.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Child, Preschool; Ethanolamines; Fluorenes; Humans; Infant; Kaplan-Meier Estimate; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Papua New Guinea; Prospective Studies; Treatment Outcome | 2013 |
Efficacy of Quinine versus Artemether in the treatment of severe malaria.
Topics: Acute Disease; Adolescent; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Coma; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Quinine; Treatment Outcome | 2013 |
A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria.
Topics: Amodiaquine; Anemia, Sickle Cell; Antimalarials; Artemether; Artemisinins; Blood Cell Count; Child; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Ghana; Hemoglobins; Humans; Lumefantrine; Malaria, Falciparum; Parasite Load; Survival Analysis | 2014 |
Therapeutic efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in North-Eastern Tanzania.
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Tanzania; Treatment Outcome | 2014 |
Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan children.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Child, Preschool; Data Collection; Drug Combinations; Ethanolamines; Female; Fever; Fluorenes; Hemoglobins; Humans; Infant; Insecticide-Treated Bednets; Lumefantrine; Malaria, Falciparum; Male; Parasite Load; Patient Compliance; Safety; Splenomegaly; Treatment Outcome; Uganda | 2014 |
Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged | 2014 |
[Comparison of the effectiveness of artemether and quinine for treatment of severe malaria in children, Bangui, Central African Republic].
Topics: Antimalarials; Artemether; Artemisinins; Central African Republic; Child, Preschool; Female; Humans; Infant; Malaria, Falciparum; Male; Quinine; Severity of Illness Index; Treatment Outcome | 2015 |
Efficacy of a novel sublingual spray formulation of artemether in African children with Plasmodium falciparum malaria.
Topics: Administration, Sublingual; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Female; Humans; Infant; Malaria, Falciparum; Male | 2015 |
Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Cohort Studies; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Middle Aged; Pregnancy; Pregnancy Complications, Parasitic; Prospective Studies; Treatment Outcome; Uganda; Young Adult | 2015 |
Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Benin.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Benin; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male | 2016 |
A Phase 3, Double-Blind, Randomized Study of Arterolane Maleate-Piperaquine Phosphate vs Artemether-Lumefantrine for Falciparum Malaria in Adolescent and Adult Patients in Asia and Africa.
Topics: Adolescent; Adult; Africa; Aged; Antimalarials; Artemether; Artemisinins; Asia; Child; Double-Blind Method; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Half-Life; Heterocyclic Compounds, 1-Ring; Humans; India; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Peroxides; Plasmodium falciparum; Quinolines; Spiro Compounds; Young Adult | 2016 |
Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial.
Topics: Antimalarials; Artemether; Artemisinins; Asymptomatic Infections; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Prevalence; Primaquine | 2016 |
Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial.
Topics: Africa South of the Sahara; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Patient Safety; Polymerase Chain Reaction | 2016 |
Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria.
Topics: Antimalarials; Artemether; Artemisinins; Black People; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Recurrence; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda | 2016 |
Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Plasmodium falciparum Malaria in Children Aged Less than 15 Years in Guinea-Bissau - An Open-Label Non-Inferiority Randomised Clinical Trial.
Topics: Antimalarials; Artemether; Artemisinins; Child; Ethanolamines; Fluorenes; Guinea-Bissau; Humans; Lumefantrine; Malaria, Falciparum; Quinolines; Treatment Outcome | 2016 |
Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Double-Blind Method; Ethanolamines; Female; Fluorenes; Humans; Immunization Schedule; Lumefantrine; Malaria, Falciparum; Male; Mali; Plasmodium falciparum; Vaccination | 2017 |
Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda.
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Fluorenes; Health Policy; Humans; Infant; Lumefantrine; Malaria, Falciparum; Quinolines; Uganda | 2008 |
Activities of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine against sexual-stage parasites in falciparum malaria in children.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sulfalene; Survival Rate; Treatment Outcome | 2008 |
Adherence and efficacy of supervised versus non-supervised treatment with artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh: a randomised controlled trial.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Directly Observed Therapy; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Medication Adherence; Middle Aged; Plasmodium falciparum; Polymerase Chain Reaction; Treatment Outcome | 2008 |
[Efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Hainan, China].
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; China; Dose-Response Relationship, Drug; Drug Combinations; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Quinolines; Treatment Outcome; Young Adult | 2008 |
Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial.
Topics: Adolescent; Adult; Artemether; Artemisinins; Atovaquone; Audiometry; Child; Ethanolamines; Ethiopia; Female; Fluorenes; Hearing Loss, Sensorineural; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Proguanil; Quinine | 2008 |
A randomized trial of artesunate-mefloquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Base Sequence; DNA Primers; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mali; Mefloquine; Plasmodium falciparum; Polymerase Chain Reaction; Treatment Outcome | 2008 |
A trial of combination antimalarial therapies in children from Papua New Guinea.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Kaplan-Meier Estimate; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Male; Proportional Hazards Models; Pyrimethamine; Quinolines; Recurrence; Sulfadoxine | 2008 |
A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy.
Topics: Adult; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Infant, Newborn; Lumefantrine; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Thailand; Young Adult | 2008 |
Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Ethanolamines; Female; Fluorenes; Humans; Logistic Models; Lumefantrine; Malaria, Falciparum; Pregnancy; Young Adult | 2009 |
Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial.
Topics: Africa; Antiparasitic Agents; Artemether; Artemisinins; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Quinolines; Time Factors | 2009 |
Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Follow-Up Studies; HIV Infections; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Male; Quinolines; Risk Factors; Treatment Outcome; Uganda | 2009 |
A randomized trial of artesunate mefloquine versus artemether lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Senegalese children.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Base Sequence; Child; Child, Preschool; DNA Primers; Female; Humans; Malaria, Falciparum; Male; Polymerase Chain Reaction | 2010 |
Therapeutic efficacy and effect on gametocyte carriage of an artemisinin and a non-based combination treatment in children with uncomplicated P. falciparum malaria, living in an area with high-level chloroquine resistance.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Gametogenesis; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfalene; Treatment Outcome | 2010 |
Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Cause of Death; Double-Blind Method; Female; Humans; Injections, Intramuscular; Kaplan-Meier Estimate; Logistic Models; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Severity of Illness Index; Treatment Outcome; Vietnam; Young Adult | 2010 |
Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.
Topics: Adolescent; Adult; Africa; Antimalarials; Artemether; Artemisinins; Artesunate; Asia; Child; Child, Preschool; Double-Blind Method; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Naphthyridines; Treatment Outcome; Young Adult | 2010 |
Azithromycin combination therapy for the treatment of uncomplicated falciparum malaria in Bangladesh: an open-label randomized, controlled clinical trial.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Azithromycin; Bangladesh; Child; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Time Factors; Treatment Outcome; Young Adult | 2010 |
Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania.
Topics: Antimalarials; Artemether; Artemisinins; Body Temperature; Child; Child, Preschool; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Tanzania; Treatment Outcome | 2010 |
Pharmacokinetic and pharmacodynamic characteristics of a new pediatric formulation of artemether-lumefantrine in African children with uncomplicated Plasmodium falciparum malaria.
Topics: Antimalarials; Artemether; Artemisinins; Child, Preschool; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male | 2011 |
Comparative study of the efficacy and tolerability of dihydroartemisinin-piperaquine-trimethoprim versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Cameroon; Child; Child, Preschool; Cote d'Ivoire; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Quinolines; Senegal; Treatment Outcome; Trimethoprim; Young Adult | 2011 |
Similar efficacy and safety of artemether-lumefantrine (Coartem®) in African infants and children with uncomplicated falciparum malaria across different body weight ranges.
Topics: Age Factors; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Body Weight; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Time Factors; Treatment Outcome | 2011 |
Artesunate + amodiaquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in the Colombian Pacific region: a noninferiority trial.
Topics: Adult; Amodiaquine; Antimalarials; Artemether; Artemisinins; Colombia; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Treatment Outcome | 2012 |
Efficacy of quinine, artemether-lumefantrine and dihydroartemisinin-piperaquine as rescue treatment for uncomplicated malaria in Ugandan children.
Topics: Antimalarials; Artemether; Artemisinins; Child, Preschool; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Quinine; Quinolines; Safety; Treatment Outcome; Uganda | 2013 |
Artemether vs quinine therapy in Plasmodium falciparum malaria in Manipur--a preliminary report.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Double-Blind Method; Female; Humans; India; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Quinine; Sesquiterpenes | 2001 |
[A study of artemether combined with primaquine in the treatment of falciparum malaria].
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Child; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Primaquine; Sesquiterpenes; Treatment Outcome | 2001 |
Comparison of intramuscular artemether and intravenous quinine in the treatment of Sudanese children with severe falciparum malaria.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Coma; Female; Fever; Humans; Infusions, Intravenous; Injections, Intramuscular; Malaria, Cerebral; Malaria, Falciparum; Male; Plasmodium falciparum; Quinine; Sesquiterpenes; Sudan; Treatment Outcome | 2002 |
Comparative clinical trial of two-fixed combinations dihydroartemisinin-napthoquine-trimethoprim (DNP) and artemether-lumefantrine (Coartem/Riamet) in the treatment of acute uncomplicated falciparum malaria in Thailand.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Sesquiterpenes; Thailand; Treatment Outcome; Trimethoprim | 2003 |
Artemether bioavailability after oral or intramuscular administration in uncomplicated falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Area Under Curve; Artemether; Artemisinins; Biological Assay; Biological Availability; Biotransformation; Chloroquine; Drug Resistance; Female; Humans; Injections, Intramuscular; Intestinal Absorption; Malaria, Falciparum; Male; Middle Aged; Quinine; Sesquiterpenes | 2003 |
Monitoring the therapeutic efficacy of antimalarials against uncomplicated falciparum malaria in Thailand.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Health Policy; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Middle Aged; Primaquine; Sesquiterpenes; Statistics, Nonparametric; Thailand; Treatment Outcome | 2003 |
A randomized, comparative study of two regimens of beta-artemether for the treatment of uncomplicated, Plasmodium falciparum malaria, in northern Ghana.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fever; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Sesquiterpenes; Treatment Outcome | 2004 |
Bayesian age-stage modelling of Plasmodium falciparum sequestered parasite loads in severe malaria patients.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Bayes Theorem; Child, Preschool; Humans; Kenya; Longitudinal Studies; Malaria, Falciparum; Markov Chains; Models, Biological; Monte Carlo Method; Parasitemia; Plasmodium falciparum; Quinine; Sesquiterpenes | 2004 |
Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Laos; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2004 |
Efficacy of artemether-lumefantrine treatment in patients with acute uncomplicated Falciparum malaria in Mayotte, a French collectivity of the Comoros Archipelago.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Comoros; Dose-Response Relationship, Drug; Drug Resistance; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Parasitic Sensitivity Tests; Plasmodium falciparum; Sesquiterpenes; Treatment Failure; Treatment Outcome | 2004 |
Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Gas Chromatography-Mass Spectrometry; Half-Life; Humans; Injections, Intramuscular; Malaria, Falciparum; Middle Aged; Sesquiterpenes; Vietnam | 2004 |
Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Biological Availability; Child; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Korea; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Sesquiterpenes; Treatment Outcome | 2004 |
In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem).
Topics: Alleles; Animals; Antimalarials; Artemether; Artemisinins; ATP-Binding Cassette Transporters; Child; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Genes, MDR; Humans; Infant; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Selection, Genetic; Sesquiterpenes | 2005 |
Efficacy of chloroquine + sulfadoxine--pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Artesunate; Bangladesh; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2005 |
Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Odds Ratio; Plasmodium falciparum; Sesquiterpenes; Tanzania | 2005 |
A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Resistance, Multiple; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Thailand | 2005 |
Successful treatment of Plasmodium falciparum malaria with a six-dose regimen of artemether-lumefantrine versus quinine-doxycycline in the Western Amazon region of Brazil.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Brazil; Doxycycline; Drug Administration Schedule; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Quinine | 2006 |
Intramuscular artemether in the treatment of uncomplicated Plasmodium falciparum malaria in Sudanese patients.
Topics: Adult; Animals; Antimalarials; Artemether; Artemisinins; Female; Hospitals, Teaching; Humans; Injections, Intramuscular; Malaria, Falciparum; Male; Plasmodium falciparum; Sudan | 2006 |
Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Body Weight; Child; Child, Preschool; Clinical Trials as Topic; Developing Countries; Endemic Diseases; Female; Humans; Infant; Injections, Intramuscular; Malaria, Falciparum; Male; Papua New Guinea; Parasitemia; Retrospective Studies; Sesquiterpenes; Severity of Illness Index; Suppositories | 2006 |
Predictors of the failure of treatment with pyrimethamine-sulfadoxine in children with uncomplicated falciparum malaria.
Topics: Aging; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Nigeria; Predictive Value of Tests; Pyrimethamine; Risk Factors; Sulfadoxine; Time Factors; Treatment Failure | 2006 |
Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; ATP-Binding Cassette Transporters; Child; Child, Preschool; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins | 2006 |
Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome | 2006 |
High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central Angola.
Topics: Amodiaquine; Angola; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Sesquiterpenes; Treatment Outcome | 2006 |
Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Directly Observed Therapy; Drug Administration Schedule; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Multivariate Analysis; Patient Compliance; Recurrence; Treatment Outcome; Uganda | 2006 |
Effects of weight, age, and time on artemether-lumefantrine associated ototoxicity and evidence of irreversibility.
Topics: Adult; Age Factors; Aged; Antimalarials; Artemether; Artemisinins; Audiometry; Body Weight; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Hearing Loss; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Mozambique; Time Factors; Treatment Outcome | 2006 |
Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults.
Topics: Adult; Animals; Antimalarials; Artemether; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Odds Ratio; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Zambia | 2006 |
Assessment of the therapeutic efficacy of a paediatric formulation of artemether-lumefantrine (Coartesiane) for the treatment of uncomplicated Plasmodium falciparum in children in Zambia.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Zambia | 2006 |
HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; CD4 Lymphocyte Count; Drug Combinations; Ethanolamines; Female; Fluorenes; HIV Infections; HIV-1; Humans; Immunosuppression Therapy; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome; Zambia | 2006 |
A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali.
Topics: Adolescent; Adult; Anemia; Antimalarials; Artemether; Artemisinins; Artesunate; Carrier State; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sesquiterpenes; Sulfalene; Treatment Outcome | 2006 |
The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Area Under Curve; Artemether; Artemisinins; Drug Administration Schedule; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Half-Life; Humans; Lumefantrine; Malaria, Falciparum; Male; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Recurrence; Remission Induction; Sesquiterpenes; Tablets; Thailand | 2006 |
Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Democratic Republic of the Congo; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome | 2006 |
Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria.
Topics: Alleles; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child, Preschool; Drug Resistance; Ethanolamines; Female; Fluorenes; Genetic Linkage; Genotype; Haplotypes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Tanzania; Treatment Outcome | 2007 |
Dihydroartemisinin suppository in moderately severe malaria: comparative efficacy of dihydroartemisinin suppository versus intramuscular artemeter followed by oral sulfadoxine-pyrimethamine in the management of moderately severe malaria in Nigerian childr
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Humans; Infant; Injections, Intramuscular; Malaria, Falciparum; Nigeria; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Suppositories | 2007 |
[Surveillance of falciparum malaria susceptibility to antimalarial drugs and policy change in the Comoros].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Chloroquine; Clinical Protocols; Comoros; Consensus Development Conferences as Topic; Drug Combinations; Drug Resistance; Ethanolamines; Female; Fluorenes; Genotype; Health Policy; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Practice Guidelines as Topic; Public Health Administration; Recurrence; World Health Organization | 2007 |
Artesunate, artemether or quinine in severe Plasmodium falciparum malaria?
Topics: Animals; Artemether; Artemisinins; Artesunate; Humans; Malaria, Falciparum; Quinine; Sesquiterpenes | 2007 |
Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda.
Topics: Alleles; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Sesquiterpenes; Treatment Outcome; Uganda | 2007 |
Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal.
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Follow-Up Studies; Humans; Infant; Lumefantrine; Malaria, Falciparum; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Senegal; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Tanzania; Treatment Outcome | 2007 |
High efficacy of two artemisinin-based combinations (artemether-lumefantrine and artesunate plus amodiaquine) for acute uncomplicated malaria in Ibadan, Nigeria.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Treatment Outcome | 2008 |
Artemether 5 versus 7 day regimen for severe falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Developing Countries; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Injections, Intramuscular; Malaria, Falciparum; Male; Middle Aged; Sesquiterpenes; Treatment Outcome | 1994 |
Artemether in moderately severe and cerebral malaria in Nigerian children.
Topics: Antimalarials; Antiprotozoal Agents; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Humans; Infant; Malaria, Cerebral; Malaria, Falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 1994 |
Artemisinin: large community studies.
Topics: Administration, Oral; Antimalarials; Antiprotozoal Agents; Artemether; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Prospective Studies; Sesquiterpenes; Suppositories | 1994 |
[Plasmodium falciparum hematozoan morphological alterations in Gabon children treated with artemether].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Child; Gabon; Humans; Malaria, Falciparum; Plasmodium falciparum; Quinine; Sesquiterpenes; Time Factors | 1995 |
A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemether; Artemisinins; Blood; Cause of Death; Double-Blind Method; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Quinine; Sesquiterpenes; Survival Analysis; Time Factors; Treatment Outcome | 1996 |
Open comparison of artemether and mefloquine in uncomplicated Plasmodium falciparum hyperparasitaemia in children.
Topics: Administration, Oral; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Erythrocytes; Female; Follow-Up Studies; Humans; Infant; Injections, Intramuscular; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Plasmodium falciparum; Retrospective Studies; Sesquiterpenes | 1996 |
Pharmacokinetics of mefloquine, when given alone and in combination with artemether, in patients with uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Biological Availability; Drug Interactions; Humans; Malaria, Falciparum; Male; Mefloquine; Sesquiterpenes | 1995 |
A comparative clinical trial of artemether and the sequential regimen of artemether-mefloquine in multidrug resistant falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Drug Administration Schedule; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes | 1995 |
Artemether-pyrimethamine in the treatment of pyrimethamine-resistant falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Treatment Outcome | 1996 |
Efficacy of artemether in severe falciparum malaria in African children.
Topics: Adolescent; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 1996 |
Chemotherapy for cerebral malaria.
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Humans; Infant; Injections, Intramuscular; Malaria, Cerebral; Malaria, Falciparum; Quinine; Sesquiterpenes; Treatment Outcome | 1996 |
Activity of artemether-azithromycin versus artemether-doxycycline in the treatment of multiple drug resistant falciparum malaria.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antimalarials; Artemether; Artemisinins; Azithromycin; Doxycycline; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Middle Aged; Sesquiterpenes; Statistics, Nonparametric | 1996 |
Compliance with a 2 day course of artemether-mefloquine in an area of highly multi-drug resistant Plasmodium falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Aged; Animals; Antimalarials; Artemether; Artemisinins; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Patient Compliance; Plasmodium falciparum; Sesquiterpenes; Thailand; Treatment Outcome | 1997 |
Open randomized trial of oral artemether alone and a sequential combination with mefloquine for acute uncomplicated falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Drug Administration Schedule; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes | 1997 |
Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Double-Blind Method; Drug Resistance, Multiple; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Prospective Studies; Sesquiterpenes; Treatment Outcome | 1998 |
A comparative study of artesunate and artemether in combination with mefloquine on multidrug resistant falciparum malaria in eastern Thailand.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes; Thailand; Treatment Outcome | 1997 |
Effect of artemether on electrocardiogram in severe falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Arrhythmias, Cardiac; Artemether; Artemisinins; Electrocardiography; Female; Humans; Hypotension; Infusions, Intravenous; Injections, Intramuscular; Injections, Intravenous; Malaria, Falciparum; Male; Middle Aged; Quinine; Sesquiterpenes | 1997 |
Pharmacokinetics of oral artemether in Thai patients with uncomplicated falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Area Under Curve; Artemether; Artemisinins; Chromatography, High Pressure Liquid; Follow-Up Studies; Humans; Malaria, Falciparum; Sesquiterpenes; Thailand | 1998 |
A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 1998 |
Plasma concentrations of artemether and its major plasma metabolite, dihydroartemisinin, following a 5-day regimen of oral artemether, in patients with uncomplicated falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Drug Resistance, Multiple; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Middle Aged; Sesquiterpenes | 1998 |
Randomized comparison of intramuscular artemether and intravenous quinine in adult, Melanesian patients with severe or complicated, Plasmodium falciparum malaria in Papua New Guinea.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Humans; Injections, Intramuscular; Injections, Intravenous; Malaria, Falciparum; Papua New Guinea; Quinine; Sesquiterpenes; Treatment Outcome | 1998 |
Two doses of artemether/mefloquine or artesunate/mefloquine combination for multidrug resistant falciparum Malaria.
Topics: Acute Disease; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes; Thailand; Treatment Outcome | 1997 |
Artemether in moderate to severe malaria: a multicenter trial in India.
Topics: Acute Disease; Adult; Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Female; Humans; India; Injections, Intramuscular; Malaria, Falciparum; Male; Recurrence; Sesquiterpenes; Severity of Illness Index; Single-Blind Method | 1997 |
Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years.
Topics: Acute Disease; Administration, Oral; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Chloroquine; Drug Administration Schedule; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Sesquiterpenes; Tanzania; Treatment Outcome | 1998 |
Pharmacokinetics of intramuscular artemether in patients with severe falciparum malaria with or without acute renal failure.
Topics: Acute Kidney Injury; Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Humans; Kidney; Malaria, Falciparum; Male; Metabolic Clearance Rate; Middle Aged; Sesquiterpenes; Treatment Outcome | 1998 |
Viability of Plasmodium falciparum ex vivo: comparison of the effects of artemether and sulfadoxine-pyrimethamine.
Topics: Adolescent; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Regression Analysis; Sesquiterpenes; Sulfadoxine; Time Factors; Treatment Outcome | 1998 |
Artesunate versus artemether for the treatment of recrudescent multidrug-resistant falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Resistance, Multiple; Female; Humans; Infant; Malaria, Falciparum; Male; Recurrence; Sesquiterpenes; Treatment Failure | 1998 |
A randomized, double-blind, comparative trial of a new oral combination of artemether and benflumetol (CGP 56697) with mefloquine in the treatment of acute Plasmodium falciparum malaria in Thailand.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Double-Blind Method; Drug Administration Schedule; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Middle Aged; Outcome Assessment, Health Care; Sesquiterpenes; Treatment Failure | 1999 |
Multiple dose pharmacokinetics of artemether in Chinese patients with uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; China; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Models, Chemical; Sesquiterpenes; Time Factors | 1999 |
[Comparative study of artemether and quinine in severe Plasmodium falciparum malaria in adults and older children in Cameroon].
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Cameroon; Child; Coma; Fever; Glasgow Coma Scale; Humans; Infusions, Intravenous; Injections, Intramuscular; Malaria, Falciparum; Middle Aged; Prospective Studies; Quinine; Sesquiterpenes; Severity of Illness Index | 1999 |
Pharmacokinetics of benflumetol given as a fixed combination artemether-benflumetol (CGP 56697) in Thai patients with uncomplicated falciparum malaria.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Random Allocation; Sesquiterpenes; Thailand; Time Factors | 1999 |
No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Therapy, Combination; Electrocardiography; Ethanolamines; Female; Fluorenes; Heart; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Sesquiterpenes | 1999 |
Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria.
Topics: Adult; Animals; Antimalarials; Area Under Curve; Artemether; Artemisinins; Biological Availability; Child; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Ethanolamines; Fluorenes; Food-Drug Interactions; Humans; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Prospective Studies; Sesquiterpenes; Treatment Outcome | 2000 |
Investigations of incidence of pretreatment, drug sensitivity in vitro, and plasma levels of pyrimethamine in patients with multidrug resistant falciparum malaria following the three combination regimens of artemether/pyrimethamine.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Humans; In Vitro Techniques; Malaria, Falciparum; Microbial Sensitivity Tests; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Statistics, Nonparametric; Thailand | 1999 |
An open study to evaluate the efficacy of artemether in severe falciparum malaria.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Malaria, Falciparum; Male; Parasitemia; Pilot Projects; Sesquiterpenes; Treatment Outcome | 1999 |
A comparison of oral artesunate and artemether antimalarial bioactivities in acute falciparum malaria.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Antimalarials; Area Under Curve; Artemether; Artemisinins; Artesunate; Biological Availability; Cross-Over Studies; Female; Humans; Malaria, Falciparum; Male; Models, Biological; Sesquiterpenes; Thailand; Time Factors | 2001 |
Dose-finding and efficacy study for i.m. artemotil (beta-arteether) and comparison with i.m. artemether in acute uncomplicated P. falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Female; Humans; Injections, Intramuscular; Malaria, Falciparum; Male; Middle Aged; Sesquiterpenes | 2002 |
Artemether in the treatment of multiple drug resistant falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Drug Resistance; Humans; Malaria, Falciparum; Sesquiterpenes; Treatment Outcome | 1992 |
Preliminary report: a comparative clinical trial of artemether and quinine in severe falciparum malaria.
Topics: Acute Kidney Injury; Adult; Antimalarials; Artemether; Artemisinins; Female; Humans; Malaria, Falciparum; Male; Quinine; Sesquiterpenes; Survival Rate; Treatment Outcome | 1992 |
Comparison of artemether and chloroquine for severe malaria in Gambian children.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Chloroquine; Gambia; Humans; Injections, Intramuscular; Malaria, Falciparum; Plasmodium falciparum; Sesquiterpenes; Severity of Illness Index | 1992 |
Comparison of oral artemether and mefloquine in acute uncomplicated falciparum malaria.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Drug Resistance; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes; Thailand | 1992 |
The effect of artemether plus mefloquine on Myanmar patients with complicated falciparum malaria.
Topics: Antimalarials; Artemether; Artemisinins; Drug Therapy, Combination; Humans; Malaria, Cerebral; Malaria, Falciparum; Mefloquine; Myanmar; Quinine; Recurrence; Sesquiterpenes; Survival Rate | 1992 |
A comparative study of the schizontocidal efficacy and safety of artemether versus chloroquine in uncomplicated malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Chloroquine; Female; Humans; Malaria, Falciparum; Male; Sesquiterpenes | 1992 |
Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand. A preliminary report.
Topics: Administration, Oral; Adolescent; Adult; Artemether; Artemisinins; Artesunate; Drug Administration Schedule; Drug Resistance; Hospitals, University; Humans; Injections, Intramuscular; Injections, Intravenous; Leukopenia; Malaria, Falciparum; Male; Microbial Sensitivity Tests; Recurrence; Sesquiterpenes; Thailand | 1991 |
174 other study(ies) available for artemether and Malaria, Falciparum
| Article | Year |
|---|---|
Spiro and dispiro-1,2,4-trioxolanes as antimalarial peroxides: charting a workable structure-activity relationship using simple prototypes.
Topics: Adamantane; Animals; Antimalarials; Cell Line, Tumor; Drug Resistance; Half-Life; Malaria; Malaria, Falciparum; Mice; Micronucleus Tests; Ozone; Peroxides; Plasmodium berghei; Rats; Spiro Compounds; Structure-Activity Relationship | 2005 |
Coumarin-trioxane hybrids: synthesis and evaluation as a new class of antimalarial scaffolds.
Topics: Aldehydes; Animals; Antimalarials; Benzenesulfonates; Coumarins; Erythrocytes; Heterocyclic Compounds; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mice; Peroxides; Plasmodium falciparum; Plasmodium yoelii; Structure-Activity Relationship | 2012 |
Artemisinin derivative-containing therapies and abnormal hemoglobin: Do we need to adapt the treatment?
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Cote d'Ivoire; Drug Combinations; Ethanolamines; Hemoglobins, Abnormal; Humans; Malaria, Falciparum; Plasmodium falciparum; Retrospective Studies; Treatment Outcome | 2021 |
Fatal case of delayed-onset haemolytic anaemia after oral artemether-lumefantrine.
Topics: Anemia, Hemolytic; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Middle Aged | 2021 |
Trends and predictive factors for treatment failure following artemisinin-based combination therapy among children with uncomplicated malaria in Ghana: 2005-2018.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ghana; Humans; Infant; Malaria; Malaria, Falciparum; Treatment Failure | 2021 |
School-Based Malaria Screening and Treatment Reduces Plasmodium falciparum Infection and Anemia Prevalence in Two Transmission Settings in Malawi.
Topics: Anemia; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Humans; Malaria; Malaria, Falciparum; Malawi; Plasmodium falciparum; Prevalence; Prospective Studies; Schools | 2022 |
Plasmodium malariae after successful treatment of P. falciparum malaria with artemether-lumefantrine.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Fluorenes; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum; Plasmodium malariae | 2022 |
Health care provider practices in diagnosis and treatment of malaria in rural communities in Kisumu County, Kenya.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Diagnostic Tests, Routine; Fever; Health Personnel; Humans; Kenya; Malaria; Malaria, Falciparum; Real-Time Polymerase Chain Reaction; Rural Population; Sensitivity and Specificity | 2022 |
Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Chloroquine; DNA Copy Number Variations; Female; Humans; Liberia; Malaria; Malaria, Falciparum; Membrane Transport Proteins; Plasmodium falciparum; Pregnancy | 2022 |
Prevalence of arps10, fd, pfmdr-2, pfcrt and pfkelch13 gene mutations in Plasmodium falciparum parasite population in Uganda.
Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Resistance; Malaria; Malaria, Falciparum; Mutation; Parasites; Plasmodium falciparum; Prevalence; Protozoan Proteins; Uganda | 2022 |
[Monitoring the Efficacy of Artemether-Lumefantrine in the Treatment of Uncomplicated
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Central African Republic; Child; Cross-Sectional Studies; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum; Mutation; Treatment Outcome | 2021 |
The effect of sickle cell genotype on the pharmacokinetic properties of artemether-lumefantrine in Tanzanian children.
Topics: Anemia, Sickle Cell; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Ethanolamines; Fluorenes; Genotype; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Tanzania | 2022 |
Multiple Plasmodium falciparum drug resistance polymorphisms identified in a pregnant woman with severe malaria and a concomitant spontaneous abortion in Cross River, Nigeria, West Africa.
Topics: Abortion, Spontaneous; Adult; Africa, Western; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Resistance; Drug Resistance, Multiple; Female; Humans; Malaria; Malaria, Falciparum; Nigeria; Plasmodium falciparum; Pregnancy; Pregnant Women; Quinine | 2022 |
Quinine plus clindamycin vs artemether-lumefantrine for treatment of uncomplicated falciparum malaria in western Kenya.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Clindamycin; Drug Combinations; Ethanolamines; Fluorenes; Humans; Kenya; Malaria, Falciparum; Quinine | 2022 |
Transmission Blocking Activity of Low-dose Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparum.
Topics: Adult; Animals; Anopheles; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Healthy Volunteers; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum; Sporozoites | 2023 |
Stakeholder perceptions on the deployment of multiple first-line therapies for uncomplicated malaria: a qualitative study in the health district of Kaya, Burkina Faso.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Burkina Faso; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Naphthyridines | 2022 |
Malaria Transmission Dynamics in a High-Transmission Setting of Western Kenya and the Inadequate Treatment Response to Artemether-Lumefantrine in an Asymptomatic Population.
Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Humans; Kenya; Malaria; Malaria, Falciparum; Parasitemia; Plasmodium falciparum | 2023 |
Plasmodium falciparum merozoite invasion ligands, linked antimalarial resistance loci and ex vivo responses to antimalarials in The Gambia.
Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Resistance; Gambia; Ligands; Lumefantrine; Malaria; Malaria, Falciparum; Merozoites; Plasmodium falciparum; Protozoan Proteins | 2022 |
Pre-existing partner-drug resistance to artemisinin combination therapies facilitates the emergence and spread of artemisinin resistance: a consensus modelling study.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Consensus; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum | 2022 |
Persistence of Residual Submicroscopic P. falciparum Parasitemia following Treatment of Artemether-Lumefantrine in Ethio-Sudan Border, Western Ethiopia.
Topics: Adolescent; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Disease Progression; Ethanolamines; Ethiopia; Fluorenes; Humans; Malaria; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Sudan; Treatment Outcome | 2022 |
Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria among Children in Western Kenya, 2016 to 2017.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ethanolamines; Fluorenes; Folic Acid Antagonists; Humans; Infant; Kenya; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines; Reinfection | 2022 |
Lumefantrine plasma concentrations in uncontrolled conditions among patients treated with artemether-lumefantrine for uncomplicated plasmodium falciparum malaria in Mwanza, Tanzania.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Male; Plasmodium falciparum; Tanzania; Treatment Outcome | 2022 |
High prevalence of Pfcrt 76T and Pfmdr1 N86 genotypes in malaria infected patients attending health facilities in East Shewa zone, Oromia Regional State, Ethiopia.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Chloroquine; Drug Resistance; Ethiopia; Genotype; Health Facilities; Humans; Malaria; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Prevalence; Protozoan Proteins | 2022 |
Impact of Drug Exposure on Resistance Selection Following Artemether-Lumefantrine Treatment for Malaria in Children With and Without HIV in Uganda.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Fluorenes; HIV Infections; Humans; Lopinavir; Lumefantrine; Malaria; Malaria, Falciparum; Nevirapine; Ritonavir; Uganda | 2023 |
Plasmodium falciparum community prevalence and health-seeking behaviours in rural Sussundenga District, Mozambique.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cross-Sectional Studies; Humans; Malaria; Malaria, Falciparum; Mozambique; Patient Acceptance of Health Care; Plasmodium falciparum; Prevalence | 2022 |
Molecular surveillance for anti-malarial drug resistance and genetic diversity of Plasmodium falciparum after chloroquine and sulfadoxine-pyrimethamine withdrawal in Quibdo, Colombia, 2018.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Chloroquine; Codon; Colombia; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sulfadoxine | 2022 |
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Chloroquine; Ghana; Humans; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine | 2022 |
High prevalence of persistent residual parasitemia on days 3 and 14 after artemether-lumefantrine or pyronaridine-artesunate treatment of uncomplicated Plasmodium falciparum malaria in Nigeria.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Humans; Malaria, Falciparum; Merozoite Surface Protein 1; Nigeria; Parasitemia; Plasmodium falciparum; Prevalence | 2023 |
Safety and therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria at Shecha health centre, Arba Minch, Ethiopia.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Ethiopia; Fever; Fluorenes; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Treatment Outcome | 2023 |
Intravenous whole blood transfusion results in faster recovery of vascular integrity and increased survival in experimental cerebral malaria.
Topics: Administration, Intravenous; Animals; Antimalarials; Artemether; Artemisinins; Blood Component Transfusion; Malaria, Cerebral; Malaria, Falciparum; Mice; Plasma | 2023 |
Return to Travel in the Coronavirus Disease 2019 Pandemic Recovery Period and Implications for Imported Malaria: Reinforcing Prevention, Early Diagnosis, and Appropriate Treatment of Malaria.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; COVID-19; COVID-19 Testing; Early Diagnosis; Humans; Malaria; Malaria, Falciparum; Pandemics; Travel; United States | 2023 |
Characterizing the Blood-Stage Antimalarial Activity of Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparum.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Australia; Healthy Volunteers; Humans; Malaria, Falciparum; Parasitemia; Plasmodium falciparum | 2023 |
Assessment of artemisinin tolerance in Plasmodium falciparum clinical isolates in children with uncomplicated malaria in Ghana.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Drug Tolerance; Ghana; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Plasmodium falciparum | 2023 |
Novel Plasmodium falciparum k13 gene polymorphisms from Kisii County, Kenya during an era of artemisinin-based combination therapy deployment.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Resistance; Humans; Kenya; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins | 2023 |
Weight-related malaria treatment failure with artemether-lumefantrine.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum; Treatment Failure | 2023 |
Impact assessment of Intensified Malaria Control Project in transitioning a high malaria-endemic district to a low-endemic district: an epidemiological aspect.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Plasmodium vivax | 2023 |
[Domestic Malaria Cases in Kayseri Province].
Topics: Adolescent; Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Parasitemia; Travel | 2023 |
Prevalence, trends and associated factors of malaria in the Shai-Osudoku District Hospital, Ghana.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Child, Preschool; Cross-Sectional Studies; Ghana; Hospitals, District; Humans; Infant; Malaria; Malaria, Falciparum; Middle Aged; Prevalence; Young Adult | 2023 |
Design, Implementation, and Coordination of Malaria Therapeutic Efficacy Studies in Nigeria in 2018.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum; Nigeria | 2023 |
Plasmodium falciparum kelch13 polymorphisms identified after treatment failure with artemisinin-based combination therapy in Niger.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Humans; Malaria, Falciparum; Niger; Plasmodium falciparum; Polymorphism, Single Nucleotide; Treatment Failure | 2023 |
Prevalence of mutations in the cysteine desulfurase IscS (Pfnfs1) gene in recurrent Plasmodium falciparum infections following artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) treatment in Matayos, Western Kenya.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Humans; Kenya; Lumefantrine; Malaria; Malaria, Falciparum; Mutation; Plasmodium falciparum; Prevalence; Quinolines; Reinfection | 2023 |
Pharmacopeial quality of artemether-lumefantrine anti-malarial agents in Uganda.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cross-Sectional Studies; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Uganda | 2023 |
Clinical isolates of uncomplicated falciparum malaria from high and low malaria transmission areas show distinct pfcrt and pfmdr1 polymorphisms in western Ethiopia.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Chloroquine; Drug Resistance; Ethiopia; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins | 2023 |
Polymorphism analysis of drug resistance markers in Plasmodium falciparum isolates from Benin.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Benin; Drug Combinations; Drug Resistance; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2023 |
Prescription patterns and compliance with World Health Organization recommendations for the management of uncomplicated and severe malaria: A prospective, real-world study in sub-Saharan Africa.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Humans; Infant, Newborn; Malaria; Malaria, Falciparum; Prescriptions; Prospective Studies; Tanzania; World Health Organization | 2023 |
Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Chad: clinical and genetic surveillance.
Topics: Adult; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Chad; Female; Humans; Malaria, Falciparum; Pregnancy; Prospective Studies | 2023 |
Modeling policy interventions for slowing the spread of artemisinin-resistant pfkelch R561H mutations in Rwanda.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Resistance; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Rwanda | 2023 |
Determine the enzymatic kinetic characteristics of CYP3A4 variants utilizing artemether-lumefantrine.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cytochrome P-450 CYP3A; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Molecular Docking Simulation | 2023 |
Attractive targeted sugar bait: the pyrrole insecticide chlorfenapyr and the anti-malarial pharmaceutical artemether-lumefantrine arrest Plasmodium falciparum development inside wild pyrethroid-resistant Anopheles gambiae s.s. mosquitoes.
Topics: Animals; Anopheles; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Carbohydrates; Female; Humans; Insecticide Resistance; Insecticides; Malaria; Malaria, Falciparum; Male; Mosquito Control; Mosquito Vectors; Plasmodium falciparum; Pyrethrins; Sugars | 2023 |
Adherence to antimalarial drug policy among doctors in Delta State, Nigeria: implications for malaria control.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Chloroquine; Drug Resistance, Microbial; Female; Guideline Adherence; Health Policy; Humans; Malaria, Falciparum; Male; Middle Aged; Nigeria; Plasmodium falciparum; Practice Guidelines as Topic; Practice Patterns, Physicians'; Quinine; Surveys and Questionnaires; Young Adult | 2019 |
Safety and tolerability of artesunate-amodiaquine, artemether-lumefantrine and quinine plus clindamycin in the treatment of uncomplicated Plasmodium falciparum malaria in Kinshasa, the Democratic Republic of the Congo.
Topics: Amodiaquine; Anti-Bacterial Agents; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child, Preschool; Clindamycin; Democratic Republic of the Congo; Drug Combinations; Female; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Quinine | 2019 |
Efavirenz-Based Antiretroviral Therapy Reduces Artemether-Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Anti-Retroviral Agents; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Benzoxazines; Cyclopropanes; Drug Combinations; Drug Interactions; Female; HIV Infections; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Pregnancy; Prospective Studies; Uganda; Young Adult | 2020 |
Plasmodium falciparum Isolates Carrying
Topics: Alleles; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cross-Sectional Studies; Drug Resistance; Humans; Indonesia; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Protozoan Proteins | 2020 |
Dolutegravir pharmacokinetics during co-administration with either artemether/lumefantrine or artesunate/amodiaquine.
Topics: Africa; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Drug Combinations; Ethanolamines; Fluorenes; Heterocyclic Compounds, 3-Ring; Humans; Malaria, Falciparum; Oxazines; Piperazines; Pyridones | 2021 |
Malaria in an asylum seeker paediatric liver transplant recipient: diagnostic challenges for migrant population.
Topics: Antimalarials; Artemether; Artesunate; Child, Preschool; Humans; Liver Transplantation; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Transients and Migrants; Transplant Recipients; Treatment Outcome | 2021 |
Protocol for a quasi-experimental study to assess the feasibility, acceptability and costs of multiple first-lines artemisinin-based combination therapies for uncomplicated malaria in the Kaya health district, Burkina Faso.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Feasibility Studies; Female; Humans; Malaria; Malaria, Falciparum; Pregnancy | 2021 |
Electrocardiographic effect of artemisinin-piperaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine treatment in falciparum malaria patients.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Electrocardiography; Humans; Malaria; Malaria, Falciparum; Quinolines | 2021 |
Reply to Rasmussen and Ringwald, "Continued Low Efficacy of Artemether-Lumefantrine in Angola?"
Topics: Angola; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Humans; Malaria, Falciparum | 2021 |
Artemether and lumefantrine dissolving microneedle patches with improved pharmacokinetic performance and antimalarial efficacy in mice infected with Plasmodium yoelii.
Topics: Animals; Antimalarials; Artemether; Female; Lumefantrine; Malaria, Falciparum; Mice; Mice, Inbred C57BL; Plasmodium yoelii | 2021 |
Antimalarial drug resistance markers in human immunodeficiency virus (HIV)-positive and HIV-negative adults with asymptomatic malaria infections in Port Harcourt, Nigeria.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Drug Resistance; HIV; Humans; Malaria; Malaria, Falciparum; Nigeria; Plasmodium falciparum; Protozoan Proteins | 2021 |
Persistent Submicroscopic Plasmodium falciparum Parasitemia 72 Hours after Treatment with Artemether-Lumefantrine Predicts 42-Day Treatment Failure in Mali and Burkina Faso.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Burkina Faso; Drug Combinations; Ethanolamines; Humans; Malaria, Falciparum; Mali; Parasitemia; Plasmodium falciparum; Treatment Failure | 2021 |
Artemether-lumefantrine treatment failure of uncomplicated Plasmodium falciparum malaria in travellers coming from Angola and Mozambique.
Topics: Angola; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Humans; Malaria, Falciparum; Male; Middle Aged; Mozambique; Plasmodium falciparum; Treatment Failure | 2021 |
The pharmacokinetic properties of artemether and lumefantrine in Malaysian patients with Plasmodium knowlesi malaria.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Male; Middle Aged; Plasmodium knowlesi | 2022 |
Artemether-Lumefantrine Treatment Failure in Nonimmune European Travelers With Plasmodium falciparum Malaria: Do We Need to Reconsider Dosing in Patients From Nonendemic Regions?
Topics: Artemether; Humans; Lumefantrine; Malaria, Falciparum; Retrospective Studies; Sweden; Treatment Failure | 2017 |
Therapeutic efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in a high-transmission area in northwest Ethiopia.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; DNA, Protozoan; Drug Combinations; Ethanolamines; Ethiopia; Female; Fluorenes; Follow-Up Studies; Headache; Hemoglobins; Humans; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Prospective Studies; Treatment Outcome; World Health Organization; Young Adult | 2017 |
MRP2/ABCC2 C1515Y polymorphism modulates exposure to lumefantrine during artemether-lumefantrine antimalarial therapy.
Topics: Antimalarials; Area Under Curve; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Genotype; Humans; Lumefantrine; Malaria, Falciparum; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Tissue Distribution | 2017 |
[Elimination in South-East Asia? The role of antimalarial drugs].
Topics: Antimalarials; Artemether; Artemisinins; Asia, Southeastern; Disease Eradication; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Quinolines | 2016 |
Antimalarial Resistance Unlikely To Explain U.K. Artemether-Lumefantrine Failures.
Topics: Antimalarials; Artemether; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Lumefantrine; Malaria, Falciparum | 2017 |
Reply to van der Pluijm et al., "Antimalarial Resistance Unlikely To Explain U.K. Artemether-Lumefantrine Failures".
Topics: Antimalarials; Artemether; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Lumefantrine; Malaria, Falciparum | 2017 |
Characteristics of Artemether-Loaded Poly(lactic-co-glycolic) Acid Microparticles Fabricated by Coaxial Electrospray: Validation of Enhanced Encapsulation Efficiency and Bioavailability.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Biological Availability; Caco-2 Cells; Drug Carriers; Drug Compounding; Drug Liberation; Female; Humans; Malaria, Falciparum; Male; Models, Animal; Particle Size; Polyesters; Polyglycolic Acid; Rats; Rats, Wistar | 2017 |
Severe delayed haemolytic anaemia associated with artemether-lumefantrine treatment of malaria in a Japanese traveller.
Topics: Administration, Intravenous; Administration, Oral; Anemia, Hemolytic; Antimalarials; Artemether; Artemisinins; Artesunate; Blackwater Fever; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Plasmodium vivax; Recurrence; Young Adult | 2018 |
A Case of Severe Plasmodium falciparum Malaria Co-Infected with HIV Improved with Exchange Transfusion.
Topics: Adult; Africa South of the Sahara; Antimalarials; Artemether; Artemisinins; Coinfection; Diagnosis, Differential; Erythrocyte Transfusion; Ethanolamines; Fluorenes; HIV Infections; Humans; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Severity of Illness Index; Travel; Turkey | 2017 |
Topics: Anti-Bacterial Agents; Antimalarials; Artemether; Artemisinins; Atovaquone; Azithromycin; Chloroquine; Doxycycline; Ethanolamines; Fluorenes; Humans; India; Lumefantrine; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 2017 |
The use and preference of artemether as a first-choice treatment for malaria: results from a cross-sectional survey in the Bata district, Equatorial Guinea.
Topics: Adolescent; Adult; Antimalarials; Artemether; Child, Preschool; Cross-Sectional Studies; Female; Guinea; Health Knowledge, Attitudes, Practice; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Young Adult | 2018 |
Population Pharmacokinetics of Artemether, Dihydroartemisinin, and Lumefantrine in Rwandese Pregnant Women Treated for Uncomplicated Plasmodium falciparum Malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Female; Humans; Lumefantrine; Malaria, Falciparum; Pregnancy; Tandem Mass Spectrometry; Young Adult | 2018 |
A barcode of multilocus nuclear DNA identifies genetic relatedness in pre- and post-Artemether/Lumefantrine treated Plasmodium falciparum in Nigeria.
Topics: Adolescent; Adult; Aged; Alleles; Antimalarials; Artemether; Child; Child, Preschool; Dihydropteroate Synthase; DNA Barcoding, Taxonomic; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Mutation; Nigeria; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Young Adult | 2018 |
Absence of
Topics: Antimalarials; Artemether; Artesunate; Brazil; Drug Combinations; Drug Resistance; Epidemiological Monitoring; Gene Expression; Genetic Markers; Genotyping Techniques; Humans; Kelch Repeat; Malaria, Falciparum; Mefloquine; Molecular Epidemiology; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Quinine | 2018 |
Semisynthetic Derivative of Artemisia annua-Loaded Transdermal Bioadhesive for the Treatment of Uncomplicated Malaria Caused by Plasmodium falciparum in Children.
Topics: Administration, Cutaneous; Animals; Antimalarials; Artemether; Artemisia annua; Child; Drug Evaluation, Preclinical; Drug Stability; Humans; Malaria, Falciparum; Permeability; Skin; Swine; Transdermal Patch | 2019 |
Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method.
Topics: Adolescent; Amodiaquine; Antimalarials; Arrhythmias, Cardiac; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Heart Rate; Humans; Long QT Syndrome; Malaria; Malaria, Falciparum; Male; Quinolines; Young Adult | 2019 |
Evolution of Plasmodium falciparum drug resistance genes following artemisinin combination therapy in Sudan.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; DNA, Protozoan; Drug Resistance; Drug Therapy, Combination; Genetic Markers; Genotype; Humans; Lumefantrine; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sudan; Sulfadoxine | 2019 |
Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda.
Topics: Adolescent; Adult; Artemether; Artemisinins; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Pregnancy; Quinine; Young Adult | 2013 |
Detecting adenosine triphosphatase 6 (pfATP6) point mutations that may be associated with Plasmodium falciparum resistance to artemisinin: prevalence at baseline, before policy change in Uganda.
Topics: Anti-Infective Agents; Artemether; Artemisinins; Calcium-Transporting ATPases; Drug Resistance, Microbial; Drug Therapy, Combination; Ethanolamines; Fluorenes; Genotype; Humans; Lumefantrine; Malaria, Falciparum; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prevalence; Sequence Analysis, DNA; Uganda | 2011 |
Quality of antimalarial drugs and antibiotics in Papua New Guinea: a survey of the health facility supply chain.
Topics: Amodiaquine; Amoxicillin; Antimalarials; Artemether; Artemisinins; Biosimilar Pharmaceuticals; Chloroquine; Drug Resistance; Health Facilities; Humans; Malaria, Falciparum; Malaria, Vivax; Papua New Guinea; Primaquine; Quality Control; Quinine | 2014 |
"Collateral" effect of artemether in an atypical kidney involvement by Plasmodium falciparum malaria: a case report.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Artemether; Artemisinins; Atovaquone; Body Temperature; Cote d'Ivoire; Creatinine; Cyclophosphamide; Drug Combinations; Female; Glomerular Filtration Rate; Humans; Immunosuppression Therapy; Kidney; Malaria, Falciparum; Methylprednisolone; Proguanil; Proteinuria; Treatment Outcome | 2014 |
Imported malaria in a non-endemic area: the experience of the university of Campinas hospital in the Brazilian Southeast.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anemia; Antimalarials; Artemether; Artemisinins; Brazil; Chloroquine; Comorbidity; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Parasitemia; Primaquine; Recurrence; Retrospective Studies; Tertiary Care Centers; Thrombocytopenia; Travel; Young Adult | 2014 |
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.
Topics: Amino Acid Substitution; Amodiaquine; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Chloroquine; Datasets as Topic; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Genetic Markers; Genotype; Humans; Infant; Kaplan-Meier Estimate; Lumefantrine; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Risk Factors | 2014 |
Antiplasmodial activity-aided isolation and identification of quercetin-4'-methyl ether in Chromolaena odorata leaf fraction with high activity against chloroquine-resistant Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Cell Line; Chloroquine; Chromolaena; Drug Resistance; Female; Inhibitory Concentration 50; Kaempferols; Lethal Dose 50; Malaria; Malaria, Falciparum; Male; Methyl Ethers; Mice; Plant Extracts; Plant Leaves; Plasmodium berghei; Plasmodium falciparum; Quercetin; Random Allocation | 2014 |
[Therapeutic effect of 138 imported falciparum malaria patients].
Topics: Adult; Africa; Antimalarials; Artemether; Artemisinins; Artesunate; China; Diagnostic Errors; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Retrospective Studies; Travel; Young Adult | 2014 |
Gametocyte Clearance Kinetics Determined by Quantitative Magnetic Fractionation in Melanesian Children with Uncomplicated Malaria Treated with Artemisinin Combination Therapy.
Topics: Antimalarials; Artemether; Artemisinins; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Half-Life; Humans; Kinetics; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Male; Naphthoquinones; Plasmodium falciparum | 2015 |
[Treated with Artemether-Lumefantrine Five Evaluation of P. Falciparum Malaria Cases in Terms of Hyponatremia and Thrombocytopenia].
Topics: Adult; Antimalarials; Artemether; Artemisinins; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Hyponatremia; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Severity of Illness Index; Thrombocytopenia; Time Factors; Treatment Outcome; Young Adult | 2015 |
Artemether-Lumefantrine Exposure in HIV-Infected Nigerian Subjects on Nevirapine-Containing Antiretroviral Therapy.
Topics: Adult; Anti-HIV Agents; Antimalarials; Artemether; Artemisinins; Case-Control Studies; Coinfection; Drug Combinations; Drug Interactions; Ethanolamines; Female; Fluorenes; HIV Infections; HIV-1; Humans; Lumefantrine; Malaria, Falciparum; Male; Nevirapine; Nigeria; Plasmodium falciparum | 2015 |
Pyrrolidine-Acridine hybrid in Artemisinin-based combination: a pharmacodynamic study.
Topics: Acridines; Animals; Antimalarials; Artemether; Artemisinins; Drug Resistance, Multiple; Drug Therapy, Combination; Lethal Dose 50; Malaria, Falciparum; Mice; Parasitemia; Plasmodium falciparum; Pyrrolidines | 2016 |
Malaria research and its influence on anti-malarial drug policy in Malawi: a case study.
Topics: Antimalarials; Artemether; Artemisinins; Biomedical Research; Chloroquine; Drug Combinations; Drug Resistance; Ethanolamines; Evidence-Based Medicine; Fluorenes; Health Policy; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malawi; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2016 |
Neutralizing Antibodies against Plasmodium falciparum Associated with Successful Cure after Drug Therapy.
Topics: Acute Disease; Adolescent; Adult; Antibodies, Neutralizing; Antibodies, Protozoan; Antibody Specificity; Antigens, Protozoan; Antimalarials; Artemether; Artemisinins; Azithromycin; Cohort Studies; Erythrocytes; Ethanolamines; Female; Fluorenes; Humans; Immune Sera; Immunity, Humoral; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Protozoan Proteins; Recurrence; Treatment Outcome | 2016 |
Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria.
Topics: Administration, Oral; Adolescent; Adult; Anemia; Antimalarials; Artemether; Artemisinins; Child; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Hemolysis; Humans; Lumefantrine; Malaria, Falciparum; Male; Prospective Studies; Quinolines | 2016 |
In vitro effects of co-incubation of blood with artemether/lumefantrine & vitamin C on the viscosity & elasticity of blood.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Ascorbic Acid; Blood Viscosity; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; In Vitro Techniques; Lumefantrine; Malaria, Falciparum | 2016 |
Efficacy of artemisinin-based combination therapies for the treatment of falciparum malaria in Pakistan (2007-2015): In vivo response and dhfr and dhps mutations.
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Ethanolamines; Female; Fluorenes; Humans; Infant; Infant, Newborn; Lumefantrine; Malaria, Falciparum; Male; Mutation; Pakistan; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Sulfadoxine | 2016 |
West Africa International Centers of Excellence for Malaria Research: Drug Resistance Patterns to Artemether-Lumefantrine in Senegal, Mali, and The Gambia.
Topics: Adolescent; Amino Acid Sequence; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Resistance; Ethanolamines; Fluorenes; Follow-Up Studies; Gambia; Genetic Loci; Humans; Lumefantrine; Malaria, Falciparum; Mali; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Senegal; Young Adult | 2016 |
Developmental toxicity studies of lumefantrine and artemether in rats and rabbits.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Embryonic Development; Ethanolamines; Female; Fetal Development; Fluorenes; Lumefantrine; Malaria, Falciparum; Male; Maternal Exposure; Pregnancy; Rabbits; Rats; Rats, Sprague-Dawley; Toxicity Tests; Toxicokinetics | 2016 |
Defining Surrogate Endpoints for Clinical Trials in Severe Falciparum Malaria.
Topics: Adult; Area Under Curve; Artemether; Artemisinins; Bangladesh; Biomarkers; Child; Clinical Trials as Topic; Coma; Databases as Topic; Glasgow Coma Scale; Humans; Lactates; Malaria, Falciparum; Quinine; Reproducibility of Results; ROC Curve | 2017 |
Efficacy of artesunate + sulphadoxine/pyrimethamine and artemether + lumefantrine and dhfr and dhps mutations in Somalia: evidence for updating the malaria treatment policy.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Dihydropteroate Synthase; Drug Resistance, Multiple; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Mutation; Plasmodium falciparum; Prospective Studies; Protozoan Proteins; Pyrimethamine; Somalia; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2017 |
Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children.
Topics: Africa; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Databases as Topic; Drug Combinations; Ethanolamines; Fluorenes; Genotype; Humans; Infant; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2008 |
Mild increases in serum hepcidin and interleukin-6 concentrations impair iron incorporation in haemoglobin during an experimental human malaria infection.
Topics: Adult; Antimalarials; Antimicrobial Cationic Peptides; Artemether; Artemisinins; Biomarkers; C-Reactive Protein; Cell Count; Erythrocytes; Ethanolamines; Female; Ferritins; Fluorenes; Hemoglobins; Hepcidins; Homeostasis; Humans; Interleukin-6; Iron; Iron, Dietary; Linear Models; Lumefantrine; Malaria, Falciparum; Male; Parasitemia; Reticulocytes; Young Adult | 2009 |
Cardiac complication after experimental human malaria infection: a case report.
Topics: Acute Coronary Syndrome; Adult; Animals; Antimalarials; Artemether; Artemisinins; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Human Experimentation; Humans; Insect Bites and Stings; Lumefantrine; Malaria Vaccines; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Treatment Outcome; Vaccination | 2009 |
Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Burkina Faso; Drug Combinations; Drug Resistance, Bacterial; Ethanolamines; Fluorenes; Genotype; Humans; Infant; Lumefantrine; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Recurrence; Sulfadoxine | 2010 |
Pyronaridine-artesunate for uncomplicated falciparum malaria.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Naphthyridines | 2010 |
Waking the sleeping beauty.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Humans; Malaria, Falciparum; Microbial Viability; Plasmodium falciparum; Recurrence | 2010 |
A liquid chromatographic-tandem mass spectrometric method for determination of artemether and its metabolite dihydroartemisinin in human plasma.
Topics: Antimalarials; Artemether; Artemisinins; Calibration; Chromatography, Liquid; Drug Therapy, Combination; Ethanolamines; Fluorenes; High-Throughput Screening Assays; Humans; Lumefantrine; Malaria, Falciparum; Reproducibility of Results; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2009 |
Automated erythrocytapheresis for severe falciparum malaria.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Australia; Automation; Blood Component Removal; Cambodia; Combined Modality Therapy; Drug Therapy, Combination; Erythrocyte Transfusion; Erythrocytes; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Parasitemia; Travel | 2011 |
Meningeal inflammation increases artemether concentrations in cerebrospinal fluid in Papua New Guinean children treated with intramuscular artemether.
Topics: Artemether; Artemisinins; Child; Child, Preschool; Female; Humans; Infant; Injections, Intramuscular; Malaria, Falciparum; Male; Meninges; Papua New Guinea; Prospective Studies | 2011 |
Identification of the Schistosoma mansoni molecular target for the antimalarial drug artemether.
Topics: Amino Acid Sequence; Animals; Antimalarials; Artemether; Artemisinins; Binding Sites; Calcium-Transporting ATPases; Computational Biology; Humans; Malaria, Falciparum; Models, Molecular; Molecular Sequence Data; Oxidation-Reduction; Plasmodium falciparum; Protein Binding; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Schistosoma mansoni; Schistosomiasis mansoni; Schistosomicides; Sequence Alignment; Species Specificity; Structural Homology, Protein; Thermodynamics | 2011 |
Plasmodium species co-infection as a cause of treatment failure.
Topics: Antimalarials; Artemether; Artemisinins; Australia; Coinfection; Drug Therapy, Combination; Ethanolamines; Fluorenes; Follow-Up Studies; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Plasmodium malariae; Travel; Treatment Outcome; Uganda | 2011 |
Falciparum--the masquerader.
Topics: Antimalarials; Artemether; Artemisinins; Biopsy; Bone Marrow; Ethanolamines; Fluorenes; Follow-Up Studies; Humans; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Platelet Transfusion; Purpura, Thrombocytopenic; Treatment Outcome; Young Adult | 2012 |
Successful oral therapy for severe falciparum malaria: the World Health Organization criteria revisited.
Topics: Administration, Oral; Adult; Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Retrospective Studies; Treatment Outcome; World Health Organization; Young Adult | 2012 |
Artemether resistance in vitro is linked to mutations in PfATP6 that also interact with mutations in PfMDR1 in travellers returning with Plasmodium falciparum infections.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Calcium-Transporting ATPases; Drug Resistance; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Models, Molecular; Multidrug Resistance-Associated Proteins; Mutation, Missense; Parasitic Sensitivity Tests; Plasmodium falciparum; Protein Binding; Travel | 2012 |
Increased urinary frequency: an unusual presentation of Plasmodium falciparum malaria.
Topics: Antimalarials; Artemether; Artemisinins; Child; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Urination Disorders | 2012 |
Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Chromatography; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mass Spectrometry; Models, Statistical; Plasma; Pregnancy; Pregnancy Complications, Infectious; Uganda; Young Adult | 2012 |
New treatment policy of malaria as a part of malaria control program in Indonesia.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Disease Eradication; Drug Resistance; Drug Therapy, Combination; Health Policy; Humans; Indonesia; Malaria, Falciparum; Malaria, Vivax; Practice Guidelines as Topic; Primaquine | 2012 |
[Hemolytic anemia in a child with malaria treated with arthemeter].
Topics: Anemia, Hemolytic; Antimalarials; Artemether; Artemisinins; Child; Humans; Malaria, Falciparum; Male | 2013 |
Are artemisinin-based combination therapies effective against Plasmodium malariae?
Topics: Adult; Antimalarials; Artemether; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; HIV Infections; Humans; Lumefantrine; Malaria, Falciparum; Male; Plasmodium malariae; Treatment Failure | 2013 |
The management of severe falciparum malaria.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Child; Community-Acquired Infections; Comorbidity; Critical Care; Cross Infection; Developing Countries; Double-Blind Method; France; Humans; Injections, Intramuscular; Injections, Intravenous; Malaria, Falciparum; Peritoneal Dialysis; Quinine; Randomized Controlled Trials as Topic; Renal Dialysis; Respiration, Artificial; Risk Factors; Sesquiterpenes; Travel; Vietnam | 2003 |
[Riamet: a new antimalarial for curative treatment of malaria].
Topics: Antimalarials; Artemether; Artemisinins; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Prognosis; Sesquiterpenes | 2002 |
[An imported case of falciparum malaria successfully treated with Artemether-Lumefantrine in Japan].
Topics: Adult; Antimalarials; Artemether; Artemisinins; Female; Ghana; Humans; Malaria, Falciparum; Sesquiterpenes; Travel | 2003 |
Presumptive artemether resistance in a patient with mixed malarial infection.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Drug Resistance, Bacterial; Female; Humans; Malaria, Falciparum; Middle Aged; Plasmodium falciparum; Sesquiterpenes | 2003 |
Neuropathological assessment of artemether-treated severe malaria.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Brain Diseases; Brain Stem; Female; Humans; Malaria, Falciparum; Male; Quinine; Sesquiterpenes | 2003 |
Clinical experience with intravenous quinine, intramuscular artemether and intravenous artesunate for the treatment of severe malaria in Thailand.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Malaria, Falciparum; Male; Middle Aged; Prospective Studies; Quinine; Sesquiterpenes; Thailand; Treatment Outcome | 2003 |
Population pharmacokinetics of artemether and dihydroartemisinin following single intramuscular dosing of artemether in African children with severe falciparum malaria.
Topics: Acidosis, Respiratory; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Female; Half-Life; Humans; Infant; Injections, Intramuscular; Malaria, Falciparum; Male; Respiratory Insufficiency; Sesquiterpenes | 2004 |
Artemether in children with severe Malaria.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Biological Availability; Child; Humans; Injections, Intramuscular; Macaca mulatta; Malaria, Falciparum; Male; Sesquiterpenes | 2004 |
[Efficacy of therapeutic combinations with artemisinin derivatives in the treatment of non complicated malaria in Burundi].
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Burundi; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Rural Health; Sesquiterpenes; Treatment Failure; Urban Health; Vomiting | 2004 |
Artemether in the treatment of falciparum malaria during pregnancy in eastern Sudan.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Birth Weight; Female; Humans; Injections, Intramuscular; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Sesquiterpenes; Sudan; Treatment Outcome | 2004 |
Adherence to a combination of artemether and lumefantrine (Coartem) in Kajo Keji, southern Sudan.
Topics: Antimalarials; Artemether; Artemisinins; Child, Preschool; Dietary Fats; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Patient Compliance; Sesquiterpenes; Sudan; Treatment Outcome | 2004 |
Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda.
Topics: Adolescent; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Patient Compliance; Plasmodium falciparum; Risk Factors; Self Administration; Sesquiterpenes; Surveys and Questionnaires; Uganda | 2004 |
[Effects of combined artemether and dihydroarteamisinin in treatment of children with falciparum malaria].
Topics: Antimalarials; Artemether; Artemisinins; Child; Drug Therapy, Combination; Humans; Malaria, Falciparum | 2005 |
Towards a proteomic definition of CoArtem action in Plasmodium falciparum malaria.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Electrophoresis, Gel, Two-Dimensional; Ethanolamines; Fluorenes; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Proteomics; Reverse Transcriptase Polymerase Chain Reaction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2005 |
Coartem (artemether-lumefantrine) in Africa: the beginning of the end?
Topics: Africa; Animals; Antimalarials; Artemether; Artemisinins; ATP-Binding Cassette Transporters; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mutation; Plasmodium falciparum; Protozoan Proteins | 2005 |
Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa.
Topics: Adolescent; Adult; Animals; Anopheles; Antimalarials; Artemether; Artemisinins; Child; Community Health Services; Drug Administration Schedule; Drug Combinations; Ethanolamines; Female; Fluorenes; Health Policy; Humans; Insect Vectors; Lumefantrine; Malaria, Falciparum; Male; Mosquito Control; Patient Compliance; Retrospective Studies; Rural Health Services; South Africa; Surveys and Questionnaires | 2005 |
Safety and efficacy of artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Ethiopia.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Ethiopia; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Prospective Studies; Safety; Treatment Outcome | 2005 |
The efficacies of artesunate-sulfadoxine-pyrimethamine and artemether-lumefantrine in the treatment of uncomplicated, Plasmodium falciparum malaria, in an area of low transmission in central Sudan.
Topics: Adolescent; Adult; Age Distribution; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Prospective Studies; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Outcome | 2006 |
Operational response to malaria epidemics: are rapid diagnostic tests cost-effective?
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Cost-Benefit Analysis; Diagnostic Tests, Routine; Disease Outbreaks; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Health Care Costs; Humans; Lumefantrine; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Sensitivity and Specificity; Sesquiterpenes | 2006 |
From chloroquine to artemisinin-based combination therapy: the Sudanese experience.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Health Policy; Humans; Lumefantrine; Malaria, Falciparum; Product Surveillance, Postmarketing; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Time Factors | 2006 |
Malaria treatment failures after artemisinin-based therapy in three expatriates: could improved manufacturer information help to decrease the risk of treatment failure?
Topics: Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Cote d'Ivoire; Dose-Response Relationship, Drug; Drug Labeling; Ethanolamines; Female; Fluorenes; Guidelines as Topic; Guinea; Humans; Lactones; Lumefantrine; Malaria, Falciparum; Parasitemia; Recurrence; Risk; Sesquiterpenes; Sudan; Switzerland; Treatment Failure; World Health Organization | 2006 |
[Severe malaria: assessment of the treatment of anaemia and cerebral manifestations in a tropical intensive cares unit].
Topics: Age Factors; Anemia; Antimalarials; Artemether; Artemisinins; Blood Transfusion; Child; Child, Preschool; Cross-Over Studies; Humans; Infant; Injections, Intramuscular; Intensive Care Units, Pediatric; Malaria, Cerebral; Malaria, Falciparum; Prognosis; Quality of Health Care; Quinine; Togo | 2006 |
Quality control of active ingredients in artemisinin-derivative antimalarials within Kenya and DR Congo.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Capsules; Chromatography, High Pressure Liquid; Democratic Republic of the Congo; Dosage Forms; Endemic Diseases; Humans; Kenya; Malaria, Falciparum; Quality Control; Sesquiterpenes; Tablets | 2007 |
In vitro assessment of artesunate, artemether and amodiaquine susceptibility and molecular analysis of putative resistance-associated mutations of Plasmodium falciparum from São Tomé and Príncipe.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Atlantic Islands; Child; Child, Preschool; Drug Resistance; Genes, Protozoan; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Sesquiterpenes | 2007 |
Resistance to artemisinin derivatives along the Thai-Cambodian border.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Cambodia; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Sesquiterpenes; Thailand | 2007 |
[Treatment of falciparum malaria with artemether-lumefantrine according to a 5-day schedule: results of a study in 21 patients and recommendations].
Topics: Adult; Aged; Antimalarials; Artemether; Artemisinins; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Ethanolamines; Feces; Female; Fluorenes; Humans; Length of Stay; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Parasite Egg Count; Recurrence; Retrospective Studies; Time Factors; Treatment Outcome | 2007 |
Plasmodium falciparum from Pará state (Brazil) shows satisfactory in vitro response to artemisinin derivatives and absence of the S769N mutation in the SERCA-type PfATPase6.
Topics: Adenosine Triphosphatases; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Brazil; Drug Resistance; Gene Dosage; Humans; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Protozoan Proteins; Sesquiterpenes | 2008 |
Anti-protozoan activities of Harungana madagascariensis stem bark extract on trichomonads and malaria.
Topics: Animals; Antimalarials; Antiprotozoal Agents; Antitrichomonal Agents; Artemether; Artemisinins; Chloroquine; Clusiaceae; Female; Malaria, Falciparum; Male; Metronidazole; Mice; Plant Bark; Plant Extracts; Plant Stems; Plasmodium falciparum; Plasmodium yoelii; Trichomonas | 2008 |
Impaired clinical response in a patient with uncomplicated falciparum malaria who received poor-quality and underdosed intramuscular artemether.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Drug Therapy; Humans; Laos; Malaria, Falciparum; Male; Treatment Outcome | 2008 |
Parasite viability during treatment of severe falciparum malaria: differential effects of artemether and quinine.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Child; Humans; Malaria, Falciparum; Plasmodium falciparum; Quinine; Sesquiterpenes | 1995 |
Artemether resistant P. falciparum.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Drug Resistance; Humans; Malaria, Falciparum; Male; Sesquiterpenes | 1995 |
Artemether saved a patient with severe falciparum malaria after quinine treatment failure (R III type of quinine resistance).
Topics: Adult; Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Humans; Malaria, Falciparum; Male; Quinine; Sesquiterpenes; Thailand; Treatment Failure | 1994 |
Pharmacokinetics of artemether after oral administration to healthy Thai males and patients with acute, uncomplicated falciparum malaria.
Topics: Administration, Oral; Adult; Animals; Antimalarials; Artemether; Artemisinins; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Sesquiterpenes; Thailand | 1994 |
Morphologic effects of artemether on Plasmodium falciparum in Aotus trivirgatus.
Topics: Animals; Antimalarials; Aotus trivirgatus; Artemether; Artemisinins; Cell Nucleus; Chromatin; Endoplasmic Reticulum; Malaria, Falciparum; Male; Microscopy, Electron; Mitochondria; Plasmodium falciparum; Sesquiterpenes | 1993 |
Intramuscular artemether in female patients with uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Female; Humans; Injections, Intramuscular; Malaria, Falciparum; Middle Aged; Sesquiterpenes | 1993 |
Comparison of beta-artemether and beta-arteether against malaria parasites in vitro and in vivo.
Topics: Animals; Antimalarials; Aotus trivirgatus; Artemether; Artemisinins; Chloroquine; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Malaria; Malaria, Falciparum; Male; Mefloquine; Mice; Plasmodium berghei; Plasmodium falciparum; Sesquiterpenes; Structure-Activity Relationship | 1993 |
Antimalarial drugs reduce cytoadherence and rosetting Plasmodium falciparum.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Cell Adhesion; Erythrocytes; Humans; In Vitro Techniques; Malaria, Falciparum; Middle Aged; Phenanthrenes; Plasmodium falciparum; Quinine; Rosette Formation; Sesquiterpenes | 1996 |
Artemether in severe malaria--still too many deaths.
Topics: Antimalarials; Artemether; Artemisinins; Drug Resistance; Humans; Malaria, Falciparum; Quinine; Sesquiterpenes | 1996 |
Back up drug found for severe malaria.
Topics: Antiprotozoal Agents; Artemether; Artemisinins; Drug Resistance; Humans; Malaria, Falciparum; Quinine; Sesquiterpenes | 1996 |
In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs.
Topics: Adult; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Drug Evaluation, Preclinical; Drug Resistance; Humans; In Vitro Techniques; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Quinine; Sesquiterpenes | 1996 |
Artemether in severe malaria.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Humans; Malaria, Falciparum; Quinine; Sesquiterpenes; Severity of Illness Index; Treatment Outcome | 1996 |
Artemether in severe malaria.
Topics: Antimalarials; Artemether; Artemisinins; Humans; Malaria, Falciparum; Quinine; Sesquiterpenes | 1996 |
Artemether treatment of recrudescent Plasmodium falciparum malaria in children.
Topics: Acute Disease; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Evaluation; Humans; Infant; Injections, Intramuscular; Malaria, Falciparum; Nigeria; Parasitemia; Prospective Studies; Recurrence; Sesquiterpenes; Time Factors | 1997 |
[Use of artemether in the treatment of severe malaria, an alternative in an unusual situation].
Topics: Adult; Antimalarials; Artemether; Artemisinins; Female; Humans; Injections, Intramuscular; Malaria, Falciparum; Parasitemia; Sesquiterpenes | 1997 |
Plasmodium falciparum: evaluation of lactate dehydrogenase in monitoring therapeutic responses to standard antimalarial drugs in Nigeria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; L-Lactate Dehydrogenase; Malaria, Falciparum; Male; Monitoring, Physiologic; Nigeria; Phenanthrenes; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 1997 |
Light microscopic changes in Plasmodium falciparum from Gabonese children treated with artemether.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Azure Stains; Blood; Child, Preschool; Erythrocytes; Gabon; Humans; Infant; Malaria, Falciparum; Microscopy; Plasmodium falciparum; Sesquiterpenes; Time Factors | 1997 |
In vitro activity of artemether against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial drugs.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Erythrocytes; Humans; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Senegal; Sesquiterpenes | 1998 |
In vitro susceptibility of Gabonese wild isolates of Plasmodium falciparum to artemether, and comparison with chloroquine, quinine, halofantrine and amodiaquine.
Topics: Adolescent; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Resistance, Microbial; Gabon; Humans; Infant; Malaria, Falciparum; Phenanthrenes; Plasmodium falciparum; Quinine; Sesquiterpenes | 1998 |
A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Audiometry; Case-Control Studies; Child; Child, Preschool; Drug Resistance, Multiple; Drug Therapy, Combination; Evoked Potentials, Auditory, Brain Stem; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Thailand | 2000 |
Antibiotics for prophylaxis of Plasmodium falciparum infections: in vitro activity of doxycycline against Senegalese isolates.
Topics: Amodiaquine; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antimalarials; Artemether; Artemisinins; Chloroquine; Doxycycline; Drug Resistance; Erythrocytes; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinine; Scintillation Counting; Senegal; Sesquiterpenes; Statistics, Nonparametric; Triazines | 2000 |
In vitro sensitivity of Plasmodium falciparum and clinical response to lumefantrine (benflumetol) and artemether.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Sesquiterpenes | 2000 |
Neurological dysfunction following malaria: disease- or drug-related?
Topics: Adult; Antimalarials; Artemether; Artemisinins; Humans; Malaria, Falciparum; Male; Nervous System Diseases; Sesquiterpenes; Tremor | 2000 |
Probable resistance to parenteral artemether in Plasmodium falciparum: case reports from Mumbai (Bombay), India.
Topics: Adult; Animals; Antimalarials; Artemether; Artemisinins; Drug Resistance; Humans; India; Malaria, Falciparum; Male; Plasmodium falciparum; Sesquiterpenes | 2000 |
Chemotherapeutic failures in Plasmodium falciparum infections.
Topics: Antimalarials; Artemether; Artemisinins; Drug Storage; Humans; Malaria, Falciparum; Sesquiterpenes; Treatment Failure | 2002 |